Chemours & Navin Fluorine Partner to Produce Liquid Cooling Product
- CC partners with Navin Fluorine to facilitate the adoption of two-phase liquid cooling.
- 05/14/2025
|
Chemours' Q1 Earnings Miss Estimates, Revenues Increase Y/Y
- CC's first-quarter earnings miss estimates, but revenues beat the same on increased sales from Titanium Technologies and Thermal & Specialized Solutions.
- 05/12/2025
|
The Chemours Company (CC) Q1 2025 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP, Investor Relations Denise Dignam - President & Chief Executive Officer Shane Hostetter - Chief Financial Officer Conference Call Participants John McNulty - BMO John Roberts - Mizuho Pete Osterland - Truist Laurence Alexander - Research Analyst Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Duffy Fischer - Goldman Sachs Mike Leithead - Barclays Operator Good morning. My name is Michelle, and I will be your conference operator today.
- 05/07/2025
|
Chemours: Dividend Cut May Signal A Bottom Is Near
- Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings, leading to a 50% drop in stock value and a 9% after-hours plunge. Despite weak performance, Chemours is nearing a potential buy point due to its free cash flow generation and strategic dividend cut to safeguard its balance sheet. CC expects sequential sales growth and a 40-45% increase in adjusted EBITDA, but the outlook remains cautious due to economic uncertainties and tariffs.
- 05/06/2025
|
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say
- The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/06/2025
|
Chemours (CC) Q1 Earnings Miss Estimates
- Chemours (CC) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.32 per share a year ago.
- 05/06/2025
|
Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture.
- 05/06/2025
|
The Chemours Company Reports First Quarter 2025 Results
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports First Quarter 2025 Results.
- 05/06/2025
|
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/29/2025
|
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call.
- 04/16/2025
|
Chemours price target lowered to $15 from $19 at Mizuho
- Mizuho analyst John Roberts lowered the firm's price target on Chemours to $15 from $19 and keeps an Outperform rating on the shares. The firm updated price targets in the chemicals, agriculture, and packaging sector to reflect the recent market multiple reductions, and only modestly reduce forward year estimates as Mizuho does not have a recession forecast. However, lower oil prices will reduce the gas-linked cost advantage for many of the basic chemical stocks, the analyst tells investors in a research note. The firm believes March quarter pre-buying for autos and electronics creates "risk for give-back near-term." 22 Apr
- 04/15/2025
|
Why Is Chemours (CC) Down 14% Since Last Earnings Report?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock?
- 03/20/2025
|
Chemours Forms Partnership With Energy Fuels to Establish Supply Chain
- CC & Energy Fuels team up to expand rare earth and critical mineral supply chains in the U.S. domestic market.
- 03/19/2025
|
Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States.
- 03/18/2025
|
Energy Fuels and Chemours Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
- DENVER , March 18, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations.
- 03/18/2025
|
Chemours, NTT DATA & Hibiya Engineering Join Forces for Product Trial
- CC partners with industry leaders to address the data center cooling gap by conducting Opteon 2P50 product trials.
- 03/17/2025
|
Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial.
- 03/14/2025
|
Chemours' Earnings Outpace Estimates, Revenues Miss in Q4
- CC's sales fall modestly as a drop in pricing is largely offset by a gain in volume, while the currency impact remains unchanged in Q4.
- 02/20/2025
|
The Long-Term Upside For Chemours Company After Q4 2024
- I've been investing in Chemours for years, despite recent accounting irregularities and share price decline since before 2024. Chemours, a leader in the titanium dioxide sector, also excels in new refrigerants like Opteon due to regulatory changes. Despite recent poor returns, I remain confident in Chemours' fundamentals and long-term potential, especially after 4Q24.
- 02/19/2025
|
Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706.
- 02/19/2025
|
The Chemours Company (CC) Q4 2024 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q4 2024 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP and CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Vincent Andrews - Morgan Stanley John Roberts - Mizuho Laurence Alexander - Jefferies Jeff Zekauskas - JPMorgan Pete Osterland - Truist Operator Good morning. My name is Michelle, and I will be your conference operator today.
- 02/18/2025
|
Chemours (CC) Reports Q4 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/18/2025
|
Chemours (CC) Q4 Earnings Beat Estimates
- Chemours (CC) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago.
- 02/18/2025
|
The Chemours Company Reports Fourth Quarter and Full Year 2024 Results
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Fourth Quarter and Full Year 2024 Results.
- 02/18/2025
|
Chemours Announces First Quarter Dividend
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces First Quarter Dividend.
- 02/14/2025
|
Chemours Appoints Leslie M. Turner to its Board of Directors
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Leslie M. Turner to its Board of Directors.
- 02/11/2025
|
Earnings Preview: Chemours (CC) Q4 Earnings Expected to Decline
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/11/2025
|
Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call.
- 02/03/2025
|
Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst
- Truist Securities analyst Peter Osterland initiated coverage on several chemicals stocks ahead of earnings release.
- 01/28/2025
|
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 5% Dividend Yields
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 01/23/2025
|
Chemours Announces Damián Gumpel as President of Titanium Technologies and Diane Picho as Chief Enterprise Enablement Officer
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours announces Damián Gumpel as President of Titanium Technologies and Diane Picho as Chief Enterprise Enablement Officer.
- 01/17/2025
|
Chemours Appoints Google Executive Joseph Kava to its Board of Directors
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Google Executive Joseph Kava to its Board of Directors.
- 01/07/2025
|
The Chemours Company Announces Completion of Euro denominated Term Loan Repricing
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Completion of Euro denominated Term Loan Repricing.
- 12/13/2024
|
Chemours and PCC Group Enter Into Chlorine Supply Agreement
- The Chemours Company CC recently announced that the PCC Group intends to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, MS. Chemours and PCC have signed a chlorine supply agreement subject to certain customary conditions.
- 12/12/2024
|
PCC Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in DeLisle, MS Along the U.S. Gulf Coast
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--PCC Group plans to build and operate a state-of-the-art chlor-alkali facility at Chemours' DeLisle, MS Titanium Dioxide Plant.
- 12/10/2024
|
Chemours (CC) Up 8.8% Since Last Earnings Report: Can It Continue?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock?
- 12/04/2024
|
The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing.
- 11/29/2024
|
The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033.
- 11/27/2024
|
Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright
- Chemours Company has underperformed the Russell 2000 and other material stocks in 2024, with negative returns of 36% on a YTD basis. Even though the current quarter is unlikely to be the greatest on account of seasonal issues, we are choosing to be cautiously optimistic on CC now. CC's most profitable division by far -Thermal & Specialized Solutions, is driving topline growth again, as regulatory tailwinds abet the Opteon portfolio.
- 11/21/2024
|
The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033.
- 11/13/2024
|
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 11/11/2024
|
Chemours' Earnings and Revenues Surpass Estimates in Q3
- CC sees record Q3 sales in the Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.
- 11/06/2024
|
The Chemours Company (CC) Q3 2024 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q3 2024 Earnings Call Transcript November 4, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Mike Leithead - Barclays Vincent Andrews - Morgan Stanley Laurence Alexander - Jefferies John Roberts - Mizuho Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Operator Good morning. My name is Daniel and I will be your conference operator today.
- 11/04/2024
|
Chemours (CC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 11/04/2024
|
Chemours (CC) Q3 Earnings and Revenues Top Estimates
- Chemours (CC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.64 per share a year ago.
- 11/04/2024
|
The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy.
- 11/04/2024
|
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/28/2024
|
Top 7 Tax-Loss Stocks To Sell By October 31, 2024
- Wolfspeed rallied due to a $750 million investment from Apollo Global Management, despite high short interest and bearish sentiment. SolarEdge Technologies faces significant competition and high inventory levels, making it a potential tax-loss selling candidate. Moderna's stock is under pressure due to declining Covid-19 vaccine demand and weakened profitability, suggesting it should be sold.
- 10/21/2024
|
Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call.
- 10/14/2024
|
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 4% Dividend Yields
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 09/25/2024
|
ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/13/2024
|
The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/12/2024
|
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 09/11/2024
|
Lost Money on The Chemours Company(CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/11/2024
|
Chemours Develops Low GWP Retrofit Approach for Vehicles
- CC anticipates its Opteon portfolio to save an estimated 325 million tons of carbon dioxide equivalent by 2025.
- 09/10/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/10/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by The Chemours Company (CC)
- NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/09/2024
|
The Chemours Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CC
- NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/07/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/07/2024
|
Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about Securities Fraud Investigation - CC
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/05/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/05/2024
|
The Chemours Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CC
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 09/05/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC).
- 09/03/2024
|
Chemours: We're Back Down To Trough And A 'BUY'
- Chemours faces operational challenges and accounting irregularities, but its position in refrigerants and crucial chemicals offers significant growth potential, outweighing current risks. Despite a 10% stock drop, 2Q24 results show resilience with $1.5B in sales and strong performance in the Titanium and Opteon segments. The company's liquidity remains strong, with over $1.5B available, and ongoing cost-saving measures are expected to drive future growth.
- 09/01/2024
|
Consumer Protection Law Firm Hagens Berman Sues 3M, Others in Class Action Alleging PFAS “Forever Chemicals” in Millions of Carpets
- MINNEAPOLIS--(BUSINESS WIRE)---- $CC #classaction--A lawsuit says homes contain carpets infused with PFAS or “forever chemicals,” which manufacturers attempted to cover up, according to Hagens Berman.
- 08/30/2024
|
CC STOCK ALERT: Levi & Korsinsky Notifies The Chemours Company Investors of an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/28/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/28/2024
|
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
- During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
- 08/28/2024
|
Lost Money on The Chemours Company (CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/28/2024
|
The Chemours Company INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by The Chemours Company (CC)
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/27/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/26/2024
|
ATTENTION CC SHAREHOLDERS: Investors who lost money on The Chemours Company are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/26/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/24/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of The Chemours Company (CC) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/23/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Clients to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/23/2024
|
ATTENTION CC SHAREHOLDERS: Investors who lost money on The Chemours Company are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/22/2024
|
CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/22/2024
|
ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/22/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/22/2024
|
ATTENTION CC SHAREHOLDERS: Investors who lost money on The Chemours Company are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/21/2024
|
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/21/2024
|
CC ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your The Chemours Company Investment
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/21/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/21/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/21/2024
|
The Chemours Company INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by The Chemours Company (CC)
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/20/2024
|
CC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/20/2024
|
Lost Money on The Chemours Company(CC)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/19/2024
|
ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/19/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/19/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by The Chemours Company (CC)
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/19/2024
|
Shareholders With Losses In The Chemours Company Encouraged To Join Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/19/2024
|
CC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of The Chemours Company Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/19/2024
|
CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/19/2024
|
Investors who lost money on The Chemours Company should contact Levi & Korsinsky about an ongoing investigation - CC
- NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/18/2024
|
The Chemours Company Investors Invited To Participate In Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/18/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/18/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK , Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/17/2024
|
Did The Chemours Company Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CC
- NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/17/2024
|
The Chemours Company Shareholders Encouraged To Join Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/17/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/16/2024
|
The Chemours Company Investors Invited To Participate In Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/16/2024
|
CC ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by The Chemours Company
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/16/2024
|
CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Stockholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/16/2024
|
Lost Money on The Chemours Company (CC)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/15/2024
|
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/15/2024
|
The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CC
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/15/2024
|
Important Investor Alert: The Schall Law Firm Urges Chemours Company Investors With Losses To Contact The Firm
- LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 08/15/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/15/2024
|
Chemours (CC) Opens Cutting-Edge Facility for EV Batteries
- Chemours (CC) opens the Chemours Battery Innovation Center to advance sustainable battery technology for electric vehicles.
- 08/15/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Stockholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/15/2024
|
Lost Money on The Chemours Company(CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/15/2024
|
CC Investors Encouraged To Join The Chemours Company Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/15/2024
|
The Chemours Company (CC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/14/2024
|
CC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/14/2024
|
Chemours Opens State-of-the-Art Battery Innovation Center to Accelerate the Evolution of Electric Vehicle Batteries
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Opens State-of-the-Art Battery Innovation Center to Accelerate the Evolution of Electric Vehicle Batteries.
- 08/13/2024
|
The Chemours Company (CC) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/13/2024
|
CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/13/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/13/2024
|
CC Investors Urged To Participate In The Chemours Company Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/13/2024
|
An Investigation Has Commenced on Behalf of The Chemours Company Shareholders. Contact Levi & Korsinsky to Discuss your CC Losses.
- NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/12/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/12/2024
|
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK--(BUSINESS WIRE)---- $CC #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC. Investigation Details On August 1, 2024, Chemours reported its financial results for the second quarter of 2024. The Compa.
- 08/11/2024
|
Did The Chemours Company Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CC
- NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/11/2024
|
CC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/11/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/11/2024
|
Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about Securities Fraud Investigation - CC
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/09/2024
|
The Chemours Company Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - CC
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/09/2024
|
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/09/2024
|
An Investigation Has Commenced on Behalf of The Chemours Company Shareholders. Contact Levi & Korsinsky to Discuss your CC Losses
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/09/2024
|
CC Investors Encouraged to Join The Chemours Company Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/09/2024
|
The Chemours Company Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - CC
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/09/2024
|
CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/09/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/09/2024
|
The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CC
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/08/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.
- 08/08/2024
|
ATTENTION CC SHAREHOLDERS: Investors who lost money on The Chemours Company are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
- 08/07/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
- NEW YORK, NY / ACCESSWIRE / August 7, 2024 / 2024 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/07/2024
|
Chemours (CC) Earnings Miss, Revenues Beat Estimates in Q2
- Chemours' (CC) earnings miss estimates in the second quarter due to lower selling prices.
- 08/05/2024
|
The Chemours Company (CC) Q2 2024 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q2 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP, CFO & Principal Accounting Officer Conference Call Participants John McNulty - BMO Capital Markets Mike Leithead - Barclays John Roberts - Mizuho Josh Spector - UBS Financial Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Arun Viswanathan - RBC Capital Markets Vincent Andrews - Morgan Stanley John McNulty - BMO Capital Markets Operator Good morning. My name is Regina and I will be your conference operator today.
- 08/02/2024
|
Chemours (CC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/01/2024
|
Chemours (CC) Misses Q2 Earnings Estimates
- Chemours (CC) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.10 per share a year ago.
- 08/01/2024
|
The Chemours Company Reports Second Quarter 2024 Results
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Second Quarter 2024 Results.
- 08/01/2024
|
Can These 4 Chemical Stocks Hit Targets This Earnings Season?
- Chemical companies are expected to have benefited from demand recovery across key end markets and moderated de-stocking activities. Let's see how APD, CE, CC and AXTA are poised ahead of their earnings releases.
- 07/31/2024
|
Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/25/2024
|
Chemours Announces Dates for Second Quarter 2024 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Second Quarter 2024 Earnings Release and Webcast Conference Call.
- 07/11/2024
|
Chemours Rises as UBS Upgrades Stock To 'Buy'
- The Chemours Co. (CC) shares gained in intraday trading Tuesday following an upgrade from UBS analysts, who said investors have been too negative on the chemical maker's stock.
- 07/09/2024
|
IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
- POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for Fiscal Year Ended March 31, 2024.
- 06/24/2024
|
The Chemours Company Resumes Production at its Titanium Dioxide Site in Altamira, Mexico
- WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced that the Mexican government has lifted its prior water intake restrictions, enabling the Company to resume normal operations at its titanium dioxide (TiO2) manufacturing facility in Altamira, Mexico. The Company previously announ.
- 06/24/2024
|
Chemours (CC) Soars 5.5%: Is Further Upside Left in the Stock?
- Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 06/14/2024
|
Chemours Names Tony Satterthwaite to Board of Directors
- WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston “Tony” Satterthwaite to its Board of Directors, effective June 12. “I'm pleased to welcome Tony as the newest member of Chemours' Board of Directors,” said Dawn Farrell, Chair of the Board of Chemours. “Tony brings e.
- 06/13/2024
|
Chemours Reaches Important Milestone in Its Sustainability Journey; Receives Approval of Science-Based Emissions Reduction Targets
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Reaches Important Milestone in its Sustainability Journey; Receives Approval of Science-Based Emissions Reduction Targets.
- 06/11/2024
|
Chemours Publishes 2023 Sustainability Report
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2023 Sustainability Report.
- 06/11/2024
|
Chemours: Upside After Irregularities, Good 2024-2026E
- Chemours' position in the market is up over 22% compared to a market only up 5% since February. The company suspended production temporarily in Mexico due to water scarcity, but the crash following the news of the audit was an overreaction. CC stock's refrigerant segment has significant potential for growth, particularly in applications like data centers.
- 06/11/2024
|
Chemours (CC) Announces Enhancement of EVOLVE 2030 Methodology
- The revised EVOLVE 2030 approach improves Chemours' (CC) ability to integrate its business processes with this goal.
- 06/06/2024
|
Chemours Appoints Shane Hostetter as Chief Financial Officer
- WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management. “Shane is a welcome addition to the.
- 06/05/2024
|
Chemours Enhances EVOLVE 2030 Portfolio Sustainability Assessment Methodology
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Enhances EVOLVE 2030 Portfolio Sustainability Assessment Methodology.
- 06/04/2024
|
The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought
- WILMINGTON, Del.--(BUSINESS WIRE)--As a result of the severe drought impacting much of Mexico, The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, today announced it is complying with a request from the government to temporarily minimize water intake, which has led to a pause in production at its Altamira Titanium Dioxide (TiO2) manufacturing facility to conserve water for the surrounding communities. Chemours remains committed to serving customers through its other world.
- 05/31/2024
|
Why Is Chemours (CC) Down 2.1% Since Last Earnings Report?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock?
- 05/30/2024
|
DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm May 20, 2024 12:53 PM EDT | Source: Schall Law Firm Los Angeles, California--(Newsfile Corp. - May 20, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024. If you are a shareholder who suffered a loss, click here to participate.We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Chemours' management team manipulated targets for free cash flow to maximize executive compensation under its Annual Incentive Plans and Long-Term Incentive Plans. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Chemours, investors suffered damages.Join the case to recover your losses.The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:The Schall Law FirmBrian Schall, Esq.,www.schallfirm.comOffice: 310-301-3335info@schallfirm.comSOURCE: The Schall Law FirmTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/209850 SOURCE: Schall Law Firm Learn more about Bill C-18 and how it will affect Canadian users when viewing news online.
- 05/20/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company - CC
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company - CC May 20, 2024 8:23 AM EDT | Source: Pomerantz LLP New York, New York--(Newsfile Corp. - May 20, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Chemours and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.You have until May 20, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Chemours securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. [Click here for information about joining the class action]On February 13, 2024, Chemours issued a press release "announc[ing] that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023, which had previously been scheduled for February 14, 2024 and February 15, 2024, respectively" and "currently expects to issue its fourth quarter and full year 2023 financial results after market close on Wednesday, February 28, 2024." Chemours stated that it "is delaying the release of financial results and the conference call because it needs additional time to complete its year-end reporting process. The Company is evaluating its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to information and communications. The Company's Audit Committee also needs additional time to complete a related internal review." On this news, Chemours's stock price fell $3.85 per share, or 12.63%, to close at $26.64 per share on February 14, 2024. Then, on February 28, 2024, Chemours issued a press release announcing that its Board of Directors had "place[d] President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave", "pending the completion of an internal review being overseen by the Audit Committee of the Board of Directors with the assistance of independent outside counsel". On this news, Chemours's stock price fell sharply during intraday trading on February 29, 2024.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980To view the source version of this press release, please visit https://www.newsfilecorp.com/release/209483 SOURCE: Pomerantz LLP
- 05/20/2024
|
CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit May 20, 2024 4:00 AM EDT | Source: Bronstein, Gewirtz & Grossman, LLC New York, New York--(Newsfile Corp. - May 20, 2024) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) and certain of its officers.Class Definition:This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CC.Case Details:According to the Complaint, Chemours, headquartered in Wilmington, Delaware, is an industrial and specialty chemical company for a number of markets including the "coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas" markets.Prior to and during the Class Period, according to the Complaint, Chemours set and publicized certain criteria for executive compensation. For example, pursuant to Chemours's Annual Incentive Plans ("AIPs") for 2022 and 2023, the Company's senior executive officers (including the CEO and CFO) were entitled to additional cash compensation if certain targets, including Free Cash Flow targets, were met. Similarly, pursuant to Chemours's Long-Term Incentive Plans ("LTIPs"), the Company's senior executive officers (including the CEO and CFO) were entitled to stock compensation if certain targets, including Free Cash Flow Conversion (defined as cash flows from operations, less purchases of property, plant, and equipment divided by Adjusted EBITDA) targets, were met.Notwithstanding Defendants' repeated assurances regarding the accuracy of the Company's financial reports and the adequacy of the Company's internal control over financial reporting, continues the Complaint, investors began to learn the truth on February 13, 2024, when Chemours "announced that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023, which had previously been scheduled for February 14, 2024 and February 15, 2024, respectively," and that it now "expect[ed] to issue its fourth quarter and full year 2023 financial results after market close on Wednesday, February 28, 2024."According to the Company, the delay was necessary "because it needs additional time to complete its year-end reporting process" and "is evaluating its internal control over financial reporting . . . with respect to maintaining effective controls related to information and communications." Chemours also revealed that it needed additional time for its Audit Committee to conduct a related internal review.In response to this initial development, the price of Chemours common stock fell $3.85 per share, or more than 12%, from a close of $30.49 per share on February 13, 2024, to close at $26.64 per share on February 14, 2024.Then, before the market opened on February 29, 2024, according to the Complaint, Chemours stunned investors when it announced that it was delaying the filing of its annual report for 2023 and that its Board of Directors (the "Board") had "place[d] President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave . . . pending the completion of an internal review being overseen by the Audit Committee of the Board of Directors with the assistance of independent outside counsel."According to the Company, the scope of the investigation "includes the processes for reviewing reports made to the Chemours Ethics Hotline" and Chemours's "practices for managing working capital, including the related impact on metrics within the Company's incentive plans [and] certain non-GAAP metrics" in the Company's financial reports. Given the importance of these issues-not only to executive compensation, but also investors' assessment of Chemours's financial performance-the Company acknowledged that it "is evaluating one or more potential material weaknesses in its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to the control environment, including the effectiveness of the 'tone at the top' set by certain members of senior management."In response to these revelations, the price of Chemours common stock plummeted $9.05 per share, or more than 31%, from a close of $28.72 per share on February 28, 2024, to close at $19.67 per share on February 29, 2024.On March 6, 2024, after the end of the Class Period, Chemours announced that the Board's Audit Committee concluded "that the members of senior management who were placed on administrative leave last week engaged in efforts in the fourth quarter of 2023 to delay payments to certain vendors that were originally due to be paid in the fourth quarter of 2023 until the first quarter of 2024, and to accelerate the collection of receivables into the fourth quarter of 2023 that were originally not due to be received until the first quarter of 2024." Critically, "[t]he Audit Committee found that these individuals engaged in these efforts in part to meet free cash flow targets that the Company had communicated publicly, and which also would be part of a key metric for determining incentive compensation applicable to executive officers." According to the Company, "[t]he Audit Committee review also determined that similar actions, though to a lesser extent, were taken in the fourth quarter of 2022, resulting in a significant increase in these cash flow measures for the quarter ended December 31, 2022, and a decrease in these measures in the first quarter of 2023."The Complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company's business and operations. Specifically, Defendants misrepresented and/or failed to disclose that:(1) certain of the Company's senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company's AIPs and LTIPs;(2) the Company's accounting practices and procedures, including its internal control over financial reporting, were deficient; and(3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.What's Next?A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CC or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Chemours you have until May 20, 2024, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.There is No Cost to YouWe represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.Why Bronstein, Gewirtz & Grossman:Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.Attorney advertising. Prior results do not guarantee similar outcomes.Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Nathanson332-239-2660 | info@bgandg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/202865 SOURCE: Bronstein, Gewirtz & Grossman, LLC
- 05/20/2024
|
Levi & Korsinsky Notifies Shareholders of The Chemours Company (CC) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80683&wire=1 or contact Joseph E. Levi, Esq.
- 05/20/2024
|
The Chemours Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CC
- NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80692&wire=1 or contact Joseph E. Levi, Esq.
- 05/20/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80663&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
Shareholders of The Chemours Company Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80662&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80656&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80657&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80622&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/19/2024
|
CC DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages The Chemours Company Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action - CC
- NEW YORK , May 19, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline. SO WHAT: If you purchased Chemours common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/19/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit - CC
- NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80594&wire=1 or contact Joseph E. Levi, Esq.
- 05/19/2024
|
Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80591&wire=1 or contact Joseph E. Levi, Esq.
- 05/18/2024
|
Class Action Filed Against The Chemours Company (CC) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80585&wire=1 or contact Joseph E. Levi, Esq.
- 05/18/2024
|
May 20, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CC
- NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80559&wire=1 or contact Joseph E. Levi, Esq.
- 05/18/2024
|
The Chemours Company Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80545&wire=1 or contact Joseph E. Levi, Esq.
- 05/18/2024
|
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/18/2024
|
Class Action Filed Against The Chemours Company (CC) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80451&wire=1 or contact Joseph E. Levi, Esq.
- 05/17/2024
|
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit
- LOS ANGELES , May 17, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC).
- 05/17/2024
|
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/17/2024
|
Shareholders of The Chemours Company Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80383&wire=1 or contact Joseph E. Levi, Esq.
- 05/17/2024
|
Investors who lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80351&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Levi & Korsinsky Notifies The Chemours Company Investors of a Class Action Lawsuit and Upcoming Deadline – CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80356&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Class Action Filed Against The Chemours Company (CC) - May 20, 2024 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80345&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit – CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80344&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Investors in The Chemours Company Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80298&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
The Chemours Company Class Action: Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80273&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Chemours Company (CC)
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 20, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On February 13, 2024, after the market closed, Chemours d.
- 05/16/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company - CC
- NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/16/2024
|
Investors in The Chemours Company Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80228&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80244&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/16/2024
|
Investors who lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80135&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Levi & Korsinsky Notifies The Chemours Company Investors of a Class Action Lawsuit and Upcoming Deadline - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80134&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Investors who lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80118&wire=1 or contact Joseph E. Levi, Esq.
- 05/16/2024
|
Levi & Korsinsky Notifies Shareholders of The Chemours Company(CC) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80099&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 – CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80087&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
May 20, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80088&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Class Action Filed Against The Chemours Company (CC) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80011&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80012&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
IMPORTANT SHAREHOLDER DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES , May 15, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/15/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79985&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
The Chemours Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79982&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before May 20, 2024.
- 05/15/2024
|
The Chemours Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79906&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79914&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about pending Class Action - CC
- NEW YORK , May 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in The Chemours Company ("The Chemours Company" or the "Company") (NYSE: CC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of The Chemours Company investors who were adversely affected by alleged securities fraud between February 10, 2023 and February 28, 2024.
- 05/15/2024
|
Shareholders that lost money on The Chemours Company(CC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79885&wire=1 or contact Joseph E. Levi, Esq.
- 05/15/2024
|
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 – CC
- NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79867&wire=1 or contact Joseph E. Levi, Esq.
- 05/14/2024
|
Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (CC)
- RADNOR, Pa. , May 14, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 and February 28, 2024, inclusive (the "Class Period").
- 05/14/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit - CC
- NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79831&wire=1 or contact Joseph E. Levi, Esq.
- 05/14/2024
|
The Chemours Company Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
- NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79835&wire=1 or contact Joseph E. Levi, Esq.
- 05/14/2024
|
Shareholders that Lost Money on The Chemours Company(CC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=79800&wire=1 or contact Joseph E. Levi, Esq.
- 05/14/2024
|
Chemours Co (CC) Q1 2024 Earnings Call Transcript
- Chemours Co (NYSE:CC ) Q1 2024 Results Conference Call May 1, 2024 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President and Chief Executive Officer Matt Abbott - Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Josh Spector - UBS Financial Hassan Ahmed - Alembic Global Advisors Mike Leithead - Barclays Turner Hinrichs - Morgan Stanley Operator Good morning. My name is Lovely, and I will be your conference operator today.
- 05/01/2024
|
Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1
- Lower volumes and prices hurt Chemours' (CC) top line in the first quarter.
- 05/01/2024
|
Chemours (CC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 04/30/2024
|
Chemours (CC) Q1 Earnings Surpass Estimates
- Chemours (CC) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.98 per share a year ago.
- 04/30/2024
|
Chemours (CC) Up 2.9% Since Last Earnings Report: Can It Continue?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock?
- 04/26/2024
|
Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call.
- 04/24/2024
|
Chemours (CC) Recently Broke Out Above the 20-Day Moving Average
- From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
- 04/02/2024
|
Chemours (CC) Just Reclaimed the 50-Day Moving Average
- From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
- 04/02/2024
|
Chemours Co (CC) Q4 2023 Earnings Call Transcript
- Chemours Co (CC) Q4 2023 Earnings Call Transcript
- 03/28/2024
|
Chemours (CC) Q4 Earnings Beat, Revenue Miss Estimates
- Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.
- 03/28/2024
|
Why Chemours Stock Is Plunging Today
- Chemours beat estimates in the fourth quarter, but the news was overshadowed by an update on an ongoing probe into the company's accounting practices. Chemours is facing a challenging environment even without the internal issues, and is best avoided for now.
- 03/28/2024
|
Chemours Stock Drops As Accounting Probe, Soft Outlook Overshadow Earnings Beat
- Shares in chemicals maker Chemours (CC) were down more than 8% in premarket trading Thursday morning as the disclosure of further details relating to an internal accounting probe and a soft current-quarter outlook overshadowed quarterly results that came in ahead of expectations.
- 03/28/2024
|
Chemours (CC) Q4 Earnings Top Estimates
- Chemours (CC) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to break-even earnings per share a year ago.
- 03/27/2024
|
Is Chemours (CC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/27/2024
|
Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call.
- 03/26/2024
|
Should Value Investors Buy Chemours (CC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/11/2024
|
Why Chemours Stock Soared Today
- Chemours concluded an internal review it announced last week. The review found that three executives shifted the timing of payables and receivables to meet free cash flow targets and bolster their incentive compensation.
- 03/07/2024
|
Why Chemours Stock Crashed 37% This Morning
- Chemours delayed issuance of its financial reports for Q4 and 2023 this morning. Management warned that when it does report, it will report a loss.
- 02/29/2024
|
Chemours Craters. Accounting Issues Delay Earnings.
- The company's board has also placed both its CEO and CFO on administrative leave.
- 02/29/2024
|
Chemical giant Chemours delays quarterly earnings release, internal review underway
- Chemours Co.'s stock dropped more than 4% in the extended session Tuesday after the chemicals company delayed its quarterly financial results, saying it “needs additional time.”
- 02/13/2024
|
Chemours Reschedules Earnings Release and Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Reschedules Earnings Release and Conference Call.
- 02/13/2024
|
Chemours (CC), DuPont & Corteva Back U.S. Water System Deal
- Chemours (CC), DuPont & Corteva do not intend to exercise the opt-out option and extend support to PFAS Deal with the U.S. Water System.
- 12/27/2023
|
Chemours: Technological Innovation Presents Excellent Opportunities For Growth
- Chemours Company has significant potential despite its leveraged debt profile, resulting in a buy rating. The company operates in three main segments: Advanced Performance Materials, Thermal and Specialized Solutions, and Titanium Technologies. Analysts have a mostly bullish view on Chemours, with an expected upside of 6.96% and a potential for solid compound returns.
- 12/22/2023
|
Chemours (CC) Sets Up International F-gas Lifecycle Program
- This program by Chemours (CC) will incorporate worldwide monitoring to stimulate further adoption, partnerships and reclamation.
- 11/29/2023
|
Companies agree to pay $110M settlement for PFAS chemicals in Ohio
- The Chemours Co. CC said Wednesday it reached a settlement with the State of Ohio along with DuPont de Nemours Inc. DD and Corteva Inc. CTVA for $110 million to resolve claims related to the manufacture and sale of per- and polyfluoroalkyl substances (PFAS). The agreement resolves Ohio's PFAS claims from the companies' facilities including the Washington Works plant along the Ohio-West Virginia border.
- 11/29/2023
|
Chemours (CC) Boosts Low GWP HFC-152a Production by 20%
- Chemours (CC) is increasing HFC-152a production by 20% at its Texas facility to meet the growing demand for eco-friendly propellants and foam-blowing agents.
- 11/15/2023
|
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 10/27/2023
|
The Chemours Company (CC) Q3 2023 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Brandon Ontjes - Vice President of FP&A and Investor Relations Mark Newman - President and Chief Executive Officer Jonathan Lock - Senior Vice President and Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Vincent Andrews - Morgan Stanley Operator Good morning. My name is Rob, and I will be your conference operator today.
- 10/27/2023
|
Compared to Estimates, Chemours (CC) Q3 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 10/26/2023
|
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
- While softer demand in certain end markets is likely to be a drag, LyondellBasell (LYB), Chemours (CC), Axalta Coating Systems (AXTA) and Ashland (ASH) are likely to have benefited from cost and pricing actions.
- 10/25/2023
|
Why Chemours (CC) Could Beat Earnings Estimates Again
- Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/23/2023
|
$7 Billion in Clean Hydrogen Grants: Winners and Losers
- The US Department of Energy finally decided who would get a piece of the $7 billion Federal funding for green hydrogen, and the news may surprise you. The funding is intended to build green hydrogen infrastructure, but the terminology would be more suitable if it read “greener” hydrogen.
- 10/16/2023
|
Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call.
- 10/06/2023
|
Here's Why You Should Hold Onto Chemours (CC) Stock For Now
- Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness.
- 09/27/2023
|
Dutch court rules Chemours liable for environmental damage caused by PFAS
- U.S. chemical company Chemours CC.N is liable for environmental damage in the Netherlands caused by PFAS chemicals, the Rotterdam District Court ruled on Wednesday.
- 09/27/2023
|
Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes
- Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.
- 08/31/2023
|
Top 5 Materials Stocks You'll Regret Missing This Quarter - Chemours (NYSE:CC), Ecovyst (NYSE:ECVT)
- The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
- 08/24/2023
|
Here's Why You Should Retain Chemours (CC) in Your Portfolio
- While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.
- 08/22/2023
|
Chemours (CC) Announces Development of New Specialty Fluid
- Chemours' (CC) introduction of Opteon 2P50 is a critical step in positioning the company to meet a growing challenge brought on by a new era of data transmission.
- 08/17/2023
|
Chemours (CC) Q2 Earnings Beat, Titanium Technologies Hurt Sales
- Chemours' (CC) Titanium Technologies sales were hurt by lower volumes due to weaker demand in all regions in Q2.
- 07/28/2023
|
Will Titanium Technologies Unit Hurt Chemours (CC) Q2 Earnings?
- Slow demand recovery in the Titanium Technologies segment is expected to have weighed on Chemours' (CC) performance in the second quarter.
- 07/24/2023
|
Chemours (CC) Scales 52-Week High: What's Driving the Stock?
- Chemours (CC) benefits from strong Opteon demand, effective execution, and its cost-reduction and pricing actions.
- 07/13/2023
|
Chemours Announces Dates for Second Quarter 2023 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release second quarter 2023 financial results after market close on July 27, 2023. The company will conduct its second quarter 2023 webcast conference call on Friday, July 28, 2023, at 8:00 a.m. Eastern Daylight Time. To allow for more Q&A.
- 07/06/2023
|
Chemours stock drops nearly 2% after final ‘forever chemicals' deal announced
- Shares of Chemours Co. CC, +2.79% dropped nearly 2% in the aftermarket Friday after the chemicals company, alongside DuPont de Nemours Inc. DD, +0.82% and Corteva Inc. CTVA, -0.69%, said it has reached a final $1.85 billion deal in principle to settle claims they are responsible for so-called “forever chemicals” in drinking water in the U.S., hewing close to what the companies announced in early June. The $1.185 billion will go into a settlement fund the three companies will establish, with Chemours contributing about 50%, or about $592 million, and DuPont, with about $400 million, and Corteva, with about $193 million, contributing the remaining 50%.
- 06/30/2023
|
3M Settles 'Forever Chemicals' Lawsuits for $10.3 Billion
- 3M agreed to pay $10.3 billion to settle "forever chemicals" lawsuits.
- 06/23/2023
|
Chemours (CC) Stock Up 16% in 3 Months: What's Driving It?
- Chemours (CC) gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.
- 06/21/2023
|
Chemours (CC) Gains on Opteon Adoption Amid Demand Woes
- While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.
- 06/13/2023
|
The 7 Best Reddit Stocks to Buy Now
- As the financial landscape evolves rapidly, it's tough to ignore the powerful influence of the Reddit community. Through forums such as r/WallStreetBets, this passionate digital collective has emerged as a robust force, driving the narrative around the best Reddit stocks.
- 06/12/2023
|
Chemours (CC) to Divest Glycolic Acid Business to PureTech
- Chemours (CC) believes that its Glycolic Acid portfolio complements PureTech's growth strategy.
- 06/07/2023
|
Strength Seen in Chemours (CC): Can Its 24.1% Jump Turn into More Strength?
- Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 06/05/2023
|
Three chemical giants agree to pay more than $1 billion to settle 'forever chemical' claims
- The companies Chemours, DuPont and Corteva announced on Friday they have agreed to pay more than $1 billion to settle claims that "forever chemicals" contaminated public US water systems.
- 06/03/2023
|
Jobs Report, Debt Ceiling Vote Send Markets Higher
- Markets rose after a strong jobs report and Senate passage of the debt ceiling bill, which will avoid a government default.
- 06/02/2023
|
Why Chemours Stock Is Up Big Today
- Chemours, along with DuPont and Corteva, have reached a $1.185 billion settlement against charges they polluted groundwater. The case has been a major overhang for Chemours shares.
- 06/02/2023
|
Chemours, DuPont, and Corteva shares rally after settlement deal in drinking water claims
- Chemours Company, DuPont (NYSE:DD) de Nemours, Inc, and Corteva, Inc have jointly announced a settlement agreement in principle to comprehensively resolve all per and polyfluoroalkyl substances (PFAS)-related drinking water claims of a defined class of public water systems that serve the vast majority of the US population. Shares of Chemours soared 25% to $33.93, while DuPont stock rose 6% to $71.60 and Corteva shares gained 3% to $55.30 in Friday morning trading.
- 06/02/2023
|
Chemours, DuPont and Corteva reach agreement to settle PFAS-related drinking water claims, but deny allegations
- The Chemours Co. CC, +2.34%, DuPont de Nemours Inc. DD, +0.37% and Corteva Inc. CTVA, +0.69% announced Friday an “agreement in principle” to settle all drinking water claims related to perfluoroalkyl and polyfluoroalkyl substances, known as PFAS. “The companies deny the allegations in the underlying litigation and reserve all legal and factual defenses against such claims if they were litigated to conclusion,” the companies said in a statement.
- 06/02/2023
|
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
- While Chemours (CC) is exposed to headwinds from demand weakness in certain businesses, it gains on healthy Opteon adoption and its pricing actions.
- 05/31/2023
|
Chemours (CC) Extends Capacity to Meet Customers' Needs
- Chemours (CC) offers a portfolio of HFO-1336mzzZ-based products that are more environmentally friendly than non-HFO alternatives.
- 05/30/2023
|
Chemours CEO on Semiconductor, EV Battery Demand
- Chemours CEO Mark Newman, discusses the companies role in semiconductors and EV space. He says Chemours is committed to making chemistry responsibly and sees a large demand for its products despite opposition from European regulators.
- 05/02/2023
|
Are Investors Undervaluing Chemours (CC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/02/2023
|
Chemours - There Is Upside After A Drop In Share Price
- Chemours is a company I've been covering for years. Challenges remain, but my long-term view for the business is a positive one. I maintain a position in CC. In this article, we'll do an update and see if the PT warrants a slight adjustment based on recent results and current global trends.
- 04/28/2023
|
The Chemours Company (CC) Q1 2023 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q1 2023 Results Conference Call April 28, 2023 8:00 AM ET Company Participants Jonathan Lock - SVP and Chief Development Officer Mark Newman - CEO, President and Director Sameer Ralhan - Senior VP and CFO Conference Call Participants Duffy Fischer - Goldman Sachs Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Capital Markets James Cannon - UBS Arun Viswanathan - RBC Capital Markets John Roberts - Credit Suisse William Tang - Morgan Stanley Laurence Alexander - Jefferies Matthew DeYoe - Bank of America Operator Good morning, and welcome to the Chemours Company First Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded.
- 04/28/2023
|
Chemours (CC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 04/27/2023
|
Chemours (CC) Surpasses Q1 Earnings Estimates
- Chemours (CC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.46 per share a year ago.
- 04/27/2023
|
Chemours Announces Dates for First Quarter 2023 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release first quarter 2023 financial results after market close on April 27, 2023. The company will conduct its first quarter 2023 webcast conference call on Friday, April 28, 2023, at 8:00 a.m. Eastern Daylight Time.
- 04/06/2023
|
7 Super Speculative Meme Stocks That Could Make You Very Rich
- If the Covid-19 pandemic taught us anything, it's that investors should never underestimate the power of coordinated trading action via social media, which brings up the topic of super speculative meme stocks. Obviously, this subsegment is highly volatile and should only be approached with money you can afford to lose.
- 04/06/2023
|
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
- While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand and its pricing actions.
- 03/28/2023
|
The chemical industry is critical to advanced electronics, says Chemours CEO
- Mark Newman, CEO of chemical company Chemours, joins Brian Sullivan and the 'CNBC Special: Taking Stock' to discuss how his company is working to expand the footprint of American manufacturing.
- 02/16/2023
|
Chemours (CC) Posts Break-Even Q4 Earnings, Sales Miss
- Chemours (CC) gains from increased prices across its segments amid headwinds from higher input cost inflation, adverse currency movements and soft demand in Europe & Asia in Q4.
- 02/13/2023
|
The Chemours Company (CC) Q4 2022 Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q4 2022 Results Earnings Conference Call February 10, 2023 8:00 AM ET Company Participants Jonathan Lock - Senior Vice President and Chief Development Officer Mark Newman - President and Chief Executive Officer Sameer Ralhan - Senior Vice President and Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs Arun Viswanathan - RBC Capital Markets John McNulty - BMO Capital Markets Matthew DeYoe - Bank of America Securities Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors Vincent Andrews - Morgan Stanley John Roberts - Credit Suisse Operator Good morning. My name is Rob and I will be your conference operator today.
- 02/10/2023
|
Chemours (CC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/10/2023
|
Chemours (CC) Reports Break-Even Earnings for Q4
- Chemours (CC) delivered earnings and revenue surprises of -100% and 5.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/09/2023
|
Chemours Announces Dates for Fourth Quarter 2022 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--( BUSINESS WIRE )--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release fourth quarter 2022 financial results after market close on February 9, 2023. The company will conduct its fourth quarter 2022 webcast conference call on Friday, February 10, 2023, at 8:00 a.m. Eastern Standard Time.
- 01/18/2023
|
Chemours: Time To Revisit And It's A 'Buy'
- My coverage of Chemours Company has been extensive, and I consider the business an interesting one in the chemical space, trading at a massive sort of discount. There are good reasons for this discount - but there are also reasons why we might choose to more or less ignore these reasons for the long-term upside.
- 12/15/2022
|
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
- There is a lot to like about The Chemours Company, but there is one issue that should give investors pause.
- 12/02/2022
|
Chemours (CC) Gains on Opteon Demand Amid Input Cost Woes
- While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.
- 11/30/2022
|
Chemours Stock Dips Amid Slowing Demand
- The shares of Chemours Co (NYSE:CC) are down 1.4% to trade at $30.96 this morning, after the company noted slowing titanium dioxide demand in Europe and Asia has its full-year earnings results falling behind its previously issued outlook.
- 11/29/2022
|
Chemours stock falls more than 5% after company says it's on pace to miss guidance
- Shares of Chemours Co. CC, -4.12% fell more than 5% in the extended session Monday after the chemicals company said it was running slightly below the low end of its full-year 2022 guidance range for an adjusted EBITDA between $1.40 billion and $1.45 billion and free cash flow of more than than $575 million. Demand for titanium dioxide has weakened in the fourth quarter, "most notably in Europe and Asia as the global outlook grows increasingly uncertain," the company said.
- 11/28/2022
|
Going Nuclear With Cameco And Energy Fuels
- In this article, we dive into the rapidly growing global nuclear energy industry fueled by the energy crisis, net-zero plans, and geopolitical risks. Moreover, there's an urgent need to source local uranium while boosting nuclear output. For now, most mining operations are in less democratic nations, which come with additional risks.
- 11/17/2022
|
New Strong Sell Stocks for October 26th
- HES, JRVR and CC have been added to the Zacks Rank #5 (Strong Sell) List on October 26, 2022.
- 10/26/2022
|
Chemours (CC) to Post Q3 Earnings: What's in the Offing?
- While Chemours (CC) is likely to have benefited from healthy demand and pricing actions, raw material inflation and ore logistics constraints are expected to have affected its performance.
- 10/19/2022
|
Chemours Announces Dates for Third Quarter 2022 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2022 Earnings Release and Webcast Conference Call
- 10/04/2022
|
Chemours: The Wrong Call Before, But Now A 'Buy'
- I wrote about Chemours a few months back, calling the company a "BUY" - shortly after that, the market dropped, and the company is down significantly more today. While it remains impossible to forecast market trends, I do remain confident in the long-term upside for Chemours.
- 10/02/2022
|
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
- While Chemours (CC) is exposed to supply-chain issues and higher input costs, it gains on healthy demand, strong execution and its cost-reduction and pricing actions.
- 09/27/2022
|
Why Shares of Chemours Plummeted This Week
- The company's bottom line in 2022 may be lower than management originally thought.
- 09/23/2022
|
Chemours stock sinks toward 6-month low after guidance cut, citing lower demand in titanium business
- Shares of Chemours Co. CC, -5.24% sank 5.5% toward a six-month low in premarket trading Wednesday, after the specialty materials company lowered its full-year outlook due to a continued demand decline in its Titanium Technologies business. The company said it now expects 2022 adjusted earnings before interest, taxes, depreciation and amortization (Ebtida) to be between $1.40 billion and $1.45 billion, down from previous guidance of "at the high end" of range of $1.475 billion to $1.575 billion.
- 09/21/2022
|
4 Stocks to Buy From the Prospering Diversified Chemical Industry
- A recovery in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. ALB, CC, UNVR and IOSP are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.
- 09/16/2022
|
5 Top-Notch Dividend Plays in the Diversified Chemical Industry
- Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.
- 09/13/2022
|
Is Chemours (CC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/06/2022
|
CC vs. PPG: Which Stock Should Value Investors Buy Now?
- CC vs. PPG: Which Stock Is the Better Value Option?
- 09/05/2022
|
Here's Why You Should Invest in Chemours (CC) Stock Now
- Chemours (CC) gains on strong end-market demand and its cost-reduction and pricing actions.
- 08/26/2022
|
Here's Why Chemours (CC) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 08/22/2022
|
Is Chemours (CC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/19/2022
|
CC or PPG: Which Is the Better Value Stock Right Now?
- CC vs. PPG: Which Stock Is the Better Value Option?
- 08/18/2022
|
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
- Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.
- 08/18/2022
|
Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?
- Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.
- 08/18/2022
|
Chemours CEO addresses Cramer's concerns about the company's potential exposure to PFAS liability
- CNBC's Jim Cramer spoke with Chemours CEO Mark Newman on Thursday's episode of "Mad Money."
- 08/04/2022
|
Should Value Investors Buy Chemours (CC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/03/2022
|
CC vs. ALB: Which Stock Is the Better Value Option?
- CC vs. ALB: Which Stock Is the Better Value Option?
- 08/02/2022
|
Are Basic Materials Stocks Lagging Chemours (CC) This Year?
- Here is how Chemours (CC) and Silica Holdings (SLCA) have performed compared to their sector so far this year.
- 08/02/2022
|
Chemours (CC) Earnings and Revenues Top Estimates in Q2
- Higher prices contribute favorably to Chemours' (CC) top-line growth in the second quarter.
- 08/01/2022
|
The Chemours Company (CC) CEO, Mark Newman on Q2 2022 Results - Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q2 2022 Earnings Conference Call July 29, 2022 8:30 AM ET Company Participants Mark Newman - President, Chief Executive Officer Sameer Ralhan - Senior Vice President, Chief Financial Officer Jonathan Lock - Senior Vice President, Chief Development Officer Conference Call Participants Arun Viswanathan - RBC Capital Markets Ross Huffman - Bank of America John McNulty - BMO Capital Markets Mike Leithead - Barclays Josh Spector - UBS Vincent Andrews - Morgan Stanley Kevin Estok - Jefferies Operator Good morning. My name is Rob and I will be your conference Operator today.
- 07/29/2022
|
Chemours (CC) Q2 Earnings and Revenues Surpass Estimates
- Chemours (CC) delivered earnings and revenue surprises of 33.10% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2022
|
Chemours stock rallies more than 6% on Q2 beat, cash flow outlook
- Shares of Chemours Co. CC, +1.99% rallied more than 6% in the extended session Thursday after the chemical company reported better-than-expected adjusted profit and sales, and increased its cash-flow outlook. Chemours said it earned $201 million, or $1.26 a share, in the second quarter, compared with $66 million, or 39 cents a share, in the year-ago quarter.
- 07/28/2022
|
Chemours Company - 'Hold' Was The Right Call - Moving To 'Buy'
- I was somewhat uncertain about my "HOLD" stance in my last article, given on how much of a tear Chemours was. However, the past 2 months have vindicated the stance. Chemours is down more than 2X the S&P 500 in the same timeframe. While this is short, it shows us that the market believed the company mispriced.
- 07/20/2022
|
Chemours Announces Dates for Second Quarter 2022 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Second Quarter 2022 Earnings Release and Webcast Conference Call
- 07/11/2022
|
Here's Why Chemours (CC) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 07/05/2022
|
Best Growth Stocks to Buy for June 29th
- CIB, CC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2022.
- 06/29/2022
|
New Strong Buy Stocks for June 27th
- BSAC, CPLP, CC, OTTR, and DELL have been added to the Zacks Rank #1 (Strong Buy) List on June 27, 2022.
- 06/27/2022
|
Best Value Stocks to Buy for June 27th
- CPLP, CC, and DELL made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 27, 2022.
- 06/27/2022
|
Best Income Stocks to Buy for June 27th
- BSAC, CPLP, and CC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 27, 2022.
- 06/27/2022
|
Chemours (CC) Stock Jumps 7.4%: Will It Continue to Soar?
- Chemours (CC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 06/27/2022
|
Buy Chemours at $30 as market valuation hits the bottom
- The Chemours Company (NYSE:CC) is trading at $30.99. The forward EPS is 4.59, placing the forward PE at 7.05.
- 06/24/2022
|
CC vs. FMC: Which Stock Should Value Investors Buy Now?
- CC vs. FMC: Which Stock Is the Better Value Option?
- 06/22/2022
|
Best Momentum Stocks to Buy for June 22nd
- CC, KR, and OSBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 22, 2022.
- 06/22/2022
|
Is Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
- Here is how Chemours (CC) and Cabot (CBT) have performed compared to their sector so far this year.
- 06/13/2022
|
US Chemicals Set for Solid Growth Despite Supply Chaos: 5 Picks
- The U.S. chemical industry is poised for strong upside this year on healthy end-market demand and inventory rebuilding. HUN, ALB, KRO, CC and UNVR are good options for investment right now.
- 06/08/2022
|
Chemours (CC) Upgraded to Strong Buy: Here's Why
- Chemours (CC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 06/07/2022
|
Chemours (CC) Stock Hits 52-Week High: What's Driving It?
- Chemours (CC) benefits from a rebound in demand from the pandemic-induced downturn, strong execution, cost-reduction and pricing actions.
- 06/07/2022
|
New Strong Buy Stocks for June 7th
- SBLK, GOGL, LPX, ASRT, and CC have been added to the Zacks Rank #1 (Strong Buy) List on June 7, 2022.
- 06/07/2022
|
Best Value Stocks to Buy for June 7th
- LPX, GOGL, and CC made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 7, 2022.
- 06/07/2022
|
Is Chemours (CC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/06/2022
|
Best Value Stocks to Buy for June 3rd
- AMR, MBUU, and CC made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 3, 2022.
- 06/03/2022
|
Here's Why You Should Invest In Chemours (CC) Stock Now
- Chemours (CC) is gaining from higher volumes on the back of strong demand, its cost and pricing actions and strong execution.
- 06/01/2022
|
Chemours (CC) Evaluates Capacity Investments for Hydrogen Economy
- Chemours' (CC) higher ionomers capacity would support demand growth within water electrolysis and fuel cell technology.
- 05/31/2022
|
Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?
- Here is how Chemours (CC) and Gerdau (GGB) have performed compared to their sector so far this year.
- 05/27/2022
|
Chemours (CC) Declares New Process for APA Grade Viton Production
- Chemours (CC) now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant.
- 05/25/2022
|
Chemours (CC) is a Great Momentum Stock: Should You Buy?
- Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 05/25/2022
|
Chemours (CC) Stock Pops 44% in 3 Months: What's Driving It?
- Chemours (CC) is benefiting from strong end-market demand and its cost-reduction and pricing actions.
- 05/24/2022
|
4 Stocks to Buy From the Promising Diversified Chemical Industry
- An upswing in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. DOW, ALB, HUN and CC are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.
- 05/20/2022
|
Is Chemours (CC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/19/2022
|
5 High Earnings Yield Value Picks Amid Market Jitters
- Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.
- 05/16/2022
|
Is Chemours (CC) a Great Stock for Value Investors?
- Is Chemours (CC) a great pick from the value investor's perspective right now? Read on to know more.
- 05/12/2022
|
5 Must-Buy Mid Cap Winners of Past Month With More Upside
- We have narrowed our search to five mid-cap stocks that have popped double-digit in the past month, with more upside. These are: LPX, GFF, PAG, CC and AVT.
- 05/12/2022
|
Chemours (CC) Shows Fast-paced Momentum But Is Still a Bargain Stock
- Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
- 05/11/2022
|
3 No-Brainer Stocks to Buy for May
- Stock investing is not easy but these 3 no-brainer stocks to buy based on their latest earnings have increased their odds of performing well in May. The post 3 No-Brainer Stocks to Buy for May appeared first on InvestorPlace.
- 05/09/2022
|
Chemours (CC) Earnings and Revenues Top Estimates in Q1
- Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.
- 05/04/2022
|
The Chemours Company (CC) CEO Mark Newman on Q1 2022 Results - Earnings Call Transcript
- The Chemours Company (NYSE:CC ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Mark Newman – President, Chief Executive Officer Sameer Ralhan – Senior Vice President, Chief Financial Officer Jonathan Lock – Senior Vice President, Chief Development Officer Conference Call Participants John McNulty – BMO Capital Markets Arun Viswanathan – RBC Capital Markets James Cannon – UBS Michael Leithead – Barclays Hassan Ahmed – Alembic Global Advisors Matthew DeYoe – Bank of America Eric Petrie – Citi Kevin Estok – Jefferies William Tang – Morgan Stanley Operator Good morning. My name is Emma and I will be your conference operator today.
- 05/03/2022
|
Why Chemours Stock Rallied as Much as 16% in Early Trading Today
- The chemicals company reported earnings and investors were clearly pleased with the news.
- 05/03/2022
|
Chemours (CC) Q1 Earnings and Revenues Beat Estimates
- Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/02/2022
|
Chemours stock rallies after Q1 beat, raised 2022 guidance
- Shares of Chemours Co. CC, +0.09% jumped nearly 7% in the extended session Monday after the the chemicals company reported first-quarter earnings that beat Wall Street expectations, saying its "outstanding" quarterly performance reflects structural improvements and longer-term growth trends for some of its businesses. Chemours said it earned $234 million, or $1.43 a share, in the quarter, compared with $96 million, or 57 cents a share, in the year-ago period.
- 05/02/2022
|
Why Chemours (CC) Might Surprise This Earnings Season
- Chemours (CC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/29/2022
|
Chemours (CC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/25/2022
|
Chemours Announces Dates for First Quarter 2022 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, announced it will release first quarter 2022 financial results after market close on May 2, 2022. The company will conduct its first quarter 2022 webcast conference call on Tuesday, May 3, 2022, at 8:30 a.m. Eastern Daylight Time. In order to
- 04/04/2022
|
Chemours (CC) is a Top-Ranked Growth Stock: Should You Buy?
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 04/04/2022
|
Chemours (CC) Gains But Lags Market: What You Should Know
- Chemours (CC) closed the most recent trading day at $29.17, moving +1.14% from the previous trading session.
- 03/17/2022
|
3 Wildly Undervalued Dividend Stocks to Buy in March
- Boost your passive income stream from three companies you can count on.
- 03/06/2022
|
17 Fair Priced 2022 Best Bet Dividends Beckon In March
- Back in November-December 2021, Kiplinger and Barron's reporters combined to list ten sets of stocks sorted as best-bets for 2022. Those ten "Best-Bets" articles revealed 123 equities, with 88 paying dividends.
- 03/03/2022
|
The Chemours Company (CC) CEO Mark Newman Q4 2021 Results - Earnings Call Transcript
- The Chemours Company (CC) CEO Mark Newman Q4 2021 Results - Earnings Call Transcript
- 02/11/2022
|
Why Chemours Stock Dropped 14.5% at the Open Today
- Shares of the specialty chemicals company didn't react well to its earnings update, though the numbers weren't exactly terrible.
- 02/11/2022
|
Chemours (CC) Earnings Miss Estimates, Revenues Top in Q4
- Volumes and prices contributed favorably to Chemours' (CC) top-line growth in the fourth quarter. It sees adjusted earnings per share in the band of $4.07-$4.70 for 2022.
- 02/11/2022
|
Chemours stock falls after company's Q4 adj. EPS falls short
- Chemours Co. stock CC, -1.58% fell more than 4% in the extended session Thursday after the chemicals company reported an adjusted profit below expectations. Chemours said it earned $233 million, or $1.40 a share, in the quarter, compared with $19 million, or 11 cents a share, in the year-ago quarter.
- 02/10/2022
|
Chemours (CC) Gains As Market Dips: What You Should Know
- Chemours (CC) closed at $33.02 in the latest trading session, marking a +0.82% move from the prior day.
- 01/25/2022
|
Why Chemours (CC) Could Beat Earnings Estimates Again
- Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/25/2022
|
3 Stocks That Are Thriving in an Inflationary Environment
- The pricing power that these companies boast make them smart stocks to buy with inflation rearing its ugly head in the economy. The post 3 Stocks That Are Thriving in an Inflationary Environment appeared first on InvestorPlace.
- 01/24/2022
|
Chemours Announces Dates for Fourth Quarter 2021 Earnings Release and Webcast Conference Call
- WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company announces dates for its fourth quarter 2021 earnings release and webcast conference call.
- 01/14/2022
|
Chemours (CC) Stock Up 32% in a Year: What's Driving It?
- Chemours (CC) benefits from strong end-market demand and its cost-reduction and pricing initiatives.
- 01/12/2022
|
Chemours (CC) Outpaces Stock Market Gains: What You Should Know
- Chemours (CC) closed the most recent trading day at $35.57, moving +1.43% from the previous trading session.
- 01/11/2022
|
3 Low Shiller Price-Earnings Ratio Stocks
- Picking stocks with compelling Shiller price-earnings ratios raises the likelihood to discover value opportunities, in my opinion. Thus, investors may want to consider the following stocks, as their Shiller price-earnings ratios are standing below the S&P 500 Index's historical average of 16.90 as of the writing of this article.
- 01/10/2022
|
Here's Why You Should Invest In Chemours (CC) Stock Now
- Chemours (CC) gains on strong end-market demand and its cost-reduction and pricing actions.
- 01/04/2022
|
Is Chemours (CC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/31/2021
|
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
- Here is how Chemours (CC) and Huntsman (HUN) have performed compared to their sector so far this year.
- 12/31/2021
|
Best Growth Stocks to Buy for December 30th
- PAM, CC, HHR, and TGLS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 30, 2021.
- 12/30/2021
|
Best Growth Stocks to Buy for December 27th
- CWK, TGLS, CC, and GGB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 27, 2021.
- 12/27/2021
|
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
- Chemours (CC) closed the most recent trading day at $31.72, moving -1.4% from the previous trading session.
- 12/24/2021
|
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
- Chemours (CC) closed at $31.72 in the latest trading session, marking a -1.4% move from the prior day.
- 12/23/2021
|
Best Growth Stocks to Buy for December 22nd
- ARCB, CC, and GEF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 22, 2021.
- 12/22/2021
|
Best Value Stocks to Buy for December 22nd
- WGO, CC, DLA, and APTS made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 22, 2021.
- 12/22/2021
|
Best Growth Stocks to Buy for December 20th
- CC, MXL, CSV, and ARCB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 20, 2021.
- 12/20/2021
|
Chemours (CC) Stock Moves -0.98%: What You Should Know
- In the latest trading session, Chemours (CC) closed at $32.42, marking a -0.98% move from the previous day.
- 12/17/2021
|
4 Reasons to Bet On Mid-Cap Value Today
- These mid-cap stocks are on sale.
- 12/15/2021
|
Is Chemours (CC) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Chemours (CC) could produce exceptional returns because of its solid growth attributes.
- 12/15/2021
|
Best Value Stocks to Buy for December 15th
- GHLD, FUNC, and CC made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 15, 2021.
- 12/15/2021
|
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
- Here is how Chemours (CC) and Nutrien (NTR) have performed compared to their sector so far this year.
- 12/15/2021
|
Should Value Investors Buy Chemours (CC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/15/2021
|
Best Growth Stocks to Buy for December 15th
- CC, LH, and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 15, 2021
- 12/15/2021
|
Best Growth Stocks to Buy for December 10th
- CC, ATCO, and CSV made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 10, 2021.
- 12/10/2021
|
Best Value Stocks to Buy for December 10th
- TMST, CC, ATCO, and HAFC made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 10, 2021.
- 12/10/2021
|
Looking for Earnings Beat? Here Are 5 Top Picks
- Top-ranked stocks LULU, AZO, CC, GS and CCRN are likely to beat on earnings and offer investors stellar gains.
- 12/09/2021
|
Fast-paced Momentum Stock Chemours (CC) Is Still Trading at a Bargain
- Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
- 12/08/2021
|
U.S. Chemicals Set for An Upswing in 2022: 5 Top Stocks to Buy
- The U.S. chemical industry is poised for an upturn next year on strong end-market demand and an upswing in chemical exports. OLN, KRO, CC, TROX and UNVR are good options for investment right now.
- 12/08/2021
|
Best Income Stocks to Buy for December 7th
- APTS, CC, BX, and FNF made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 7, 2021.
- 12/07/2021
|
Best Value Stocks to Buy for December 7th
- MRBK, FNF, CC, and SIG made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 7, 2021.
- 12/07/2021
|
Best Growth Stocks to Buy for December 7th
- CC, CPRI, SIG, and CSV made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 7, 2021.
- 12/07/2021
|
Chemours (CC) Closes Mining Solutions Unit Sale to Draslovka
- Chemours (CC) completes Mining Solutions sale and aims to focus on the growth of its main units.
- 12/06/2021
|
3 Bargain-Bin Value Stocks That Are Too Cheap to Ignore
- This basket of value and dividend stocks can help you sleep at night.
- 12/05/2021
|
Ida Pulls Down US Chemical Output as Supply Chain Woes Linger
- The October reading showed lower production on a monthly comparison basis across all regions barring Northeast, reflecting the lingering impacts of Hurricane Ida and supply chain disruptions.
- 12/03/2021
|
5 Chemical Growth Stocks to Buy on Industry's Positive Momentum
- Strong end-market demand driven by higher industrial activities is expected to help the chemical industry to continue the momentum through this year. CC, OLN, ASIX, MEOH and TROX are worth betting on right now.
- 12/02/2021
|
Best Value Stocks to Buy for December 1st
- CC, SBFG, and UFI made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 1, 2021.
- 12/01/2021
|
Best Growth Stocks to Buy for December 1st
- ARCB, CSV, and CC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 1, 2021.
- 12/01/2021
|
Wall Street Analysts Believe Chemours (CC) Could Rally 27%: Here's is How to Trade
- The mean of analysts' price targets for Chemours (CC) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- 12/01/2021
|
New Strong Buy Stocks for December 1st
- CC, FORR, GFED, HUBG, and JD have been added to the Zacks Rank #1 (Strong Buy) List on December 1st.
- 12/01/2021
|
CC vs. ALB: Which Stock Should Value Investors Buy Now?
- CC vs. ALB: Which Stock Is the Better Value Option?
- 11/30/2021
|
Should You Buy the Dip on the Omicron Scare?
- We can make the most of the current volatility in the market to load up on some shares.
- 11/29/2021
|
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
- Here is how Chemours (CC) and Nutrien (NTR) have performed compared to their sector so far this year.
- 11/29/2021
|
Best Income Stocks to Buy for November 29th
- BP, CC, E, and HAFC made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 29, 2021.
- 11/29/2021
|
5 Value Picks as 2022 Approaches
- There is value in stocks trading at a discount to their 2022 estimates.
- 11/23/2021
|
Best Growth Stocks to Buy for November 22nd
- CC, NVMI, OLN, and ARCB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 22, 2021.
- 11/22/2021
|
Best Value Stocks to Buy for November 22nd
- PAG, CC, RM, and SPH made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 22, 2021.
- 11/22/2021
|
What Makes Chemours (CC) Stock a Solid Choice Right Now
- Chemours (CC) benefits from strong end-market demand and its cost-reduction and pricing actions.
- 11/22/2021
|
Chemours (CC) Adds Glyclean D to its Glycolic Acid Portfolio
- Chemours' (CC) new disinfectant product, Glyclean D, promises to be an environmental-friendly household cleaner.
- 11/19/2021
|
Best Growth Stocks to Buy for November 16th
- TGLS, CC, and DDS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 16, 2021.
- 11/16/2021
|
Inflation Hasn't Hurt Sentiment, but Should You Play It Safe?
- A safe strategy with huge potential.
- 11/11/2021
|
Best Growth Stocks to Buy for November 11th
- TGLS, CC, and NMRK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2021.
- 11/11/2021
|
New Strong Buy Stocks for November 11th
- BLDR, FLGT, MRBK, CC, and NMRK have been added to the Zacks Rank #1 (Strong Buy) List on November 11th.
- 11/11/2021
|
Is Chemours (CC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/10/2021
|
The Chemours Company (CC) CEO Mark Newman on Q3 2021 Results - Earnings Call Transcript
- The Chemours Company (CC) CEO Mark Newman on Q3 2021 Results - Earnings Call Transcript
- 11/05/2021
|
Chemours (CC) Earnings and Revenues Surpass Estimates in Q3
- Chemours (CC) benefits from strengthening pricing across its portfolio and higher volumes on strong demand in Q3.
- 11/05/2021
|
Chemours (CC) to Report Q3 Earnings: What's in Store?
- Chemours' (CC) third-quarter performance is likely to reflect increasing customer adoption of Opteon refrigerants and the benefits from cost-cutting measures.
- 11/02/2021
|
Here's Why Chemours (CC) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/01/2021
|
5 Mid-Cap Growth Picks Ahead of Earnings for Long-Term Gain
- We have narrowed down our search to five mid-cap growth stocks that will report earnings results within next week. These are: RL, SYNA, CC, CRI and CWK.
- 10/28/2021
|
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
- Is (CC) Outperforming Other Basic Materials Stocks This Year?
- 10/27/2021
|
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
- In the latest trading session, Chemours (CC) closed at $28.95, marking a -1.63% move from the previous day.
- 10/26/2021
|
Are Investors Undervaluing Chemours (CC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/25/2021
|
Will Chemours (CC) Beat Estimates Again in Its Next Earnings Report?
- Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/19/2021
|
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
- Chemours (CC) closed the most recent trading day at $30.64, moving -0.81% from the previous trading session.
- 10/18/2021
|
Chemours (CC) Dips More Than Broader Markets: What You Should Know
- Chemours (CC) closed at $30.91 in the latest trading session, marking a -1.47% move from the prior day.
- 10/12/2021
|
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
- Is (CC) Outperforming Other Basic Materials Stocks This Year?
- 10/11/2021
|
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
- Chemours (CC) closed at $29.90 in the latest trading session, marking a -1.61% move from the prior day.
- 10/06/2021
|
NHL and Chemours Announce Multiyear Partnership Renewal, Expanding Successful Collaboration on Sustainable Solutions for Community Rinks Across North America
- NEW YORK and TORONTO, Oct. 6, 2021 /PRNewswire/ -- The National Hockey League® (NHL) and The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, announced today their multiyear renewal of a partnership that started in 2018 and continues to provide education, technical support, innovation and sustainable solutions with Opteon™ refrigerants to support the NHL's commitment to ensuring all levels of hockey thrive for future generations. In addition, the partnership will expand beyond ice rinks and into the classroom via support of Chemours' middle school partnership program to inspire the next generation of STEM professionals, while fostering values core to both organizations, such as integrity, respect, courage, teamwork, perseverance, and acceptance.
- 10/06/2021
|
Chemours Titanium Technologies Announces First Annual Carrier of the Year Award
- WILMINGTON, Del., Oct. 5, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, today announced the winners of its first annual Carrier of the Year Award: Marten Transport (Platinum award) and Freightworks Transportation & Logistics (Gold award).
- 10/05/2021
|
5 Top High-Yield Dividend Stocks to Buy Heading Into Q4
- From the rise in bond yields, budget slowdown and dent in consumer confidence, things are looking volatile for stocks heading into Q4. This calls for investing in dividend stocks like Chemours (CC) & Hanesbrands (HBI).
- 09/29/2021
|
Top Ranked Growth Stocks to Buy for September 29th
- GIL, CC, DDS, and TGLS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 29, 2021.
- 09/29/2021
|
Ida, Supply Constraints Dent US Chemicals as August Output Dips
- The August reading showed lower production on a monthly comparison basis across all regions barring Northeast, reflecting the impacts of Hurricane Ida and supply-chain disruptions.
- 09/28/2021
|
Chemours (CC) Surges 9.4%: Is This an Indication of Further Gains?
- Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 09/28/2021
|
Why Shares in Chemours Soared More Than 10% Today
- Value investors have started buying into this unloved sector, even on bad news.
- 09/27/2021
|
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
- Is (CC) Outperforming Other Basic Materials Stocks This Year?
- 09/24/2021
|
Here's What Makes Chemours (CC) Stock A Solid Bet Right Now
- Chemours (CC) benefits from demand revival across all markets, strong execution and its cost-reduction actions.
- 09/23/2021
|
New Strong Buy Stocks for September 22nd
- BRBR, CNHI, MCFT, CC, and UFI have been added to the Zacks Rank #1 (Strong Buy) List on September 22, 2021.
- 09/22/2021
|
Top Ranked Value Stocks to Buy for September 22nd
- CCS, PCB, CC, and CVLG made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 22, 2021.
- 09/22/2021
|
Top Ranked Income Stocks to Buy for September 22nd
- ETD, FNF, CC, and FCBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 22, 2021.
- 09/22/2021
|
5 Chemical Stocks Set to Run Higher Despite Supply-Chain Woes
- While input cost inflation and supply chain constraints pose headwinds, the chemical industry is expected to benefit from strong demand across major markets. AVNT, MEOH, CC, OLN, IOSP are good options for investment right now.
- 09/16/2021
|
“Yes in My Backyard”: How the Shift from China-Made Goods to American-Made is Revving Up to be the Next Big Trend
- The rare earth element supply chain is critical to manufacturing, and efforts are being made to bring that process to the U.S. The post “Yes in My Backyard”: How the Shift from China-Made Goods to American-Made is Revving Up to be the Next Big Trend appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America's #1 EV Stock Still Flying Under the Radar
- 09/15/2021
|
Chemours (CC) Stock Up 28% YTD: What's Driving the Rally?
- Chemours (CC) benefits from demand revival across all markets and regions and its productivity and operational improvement actions.
- 09/10/2021
|
What Stocks Could Gain When the Chip Shortage Ends? It's More Than Just Car Makers.
- Semiconductors of all shapes and sizes will remain scarce well into next year, but BMO Capital Markets says the worst of the shortage may well be past.
- 09/09/2021
|
4 Diversified Chemical Stocks to Watch Out for Amid Industry Woes
- Raw material cost pressure and demand worries due to chip shortage and the spread of the Delta variant pose as headwinds for the Zacks Chemicals Diversified industry. DOW, OLN, CC and AVNT are poised to survive the industry challenges.
- 09/08/2021
|
Chemours: A Quick Look At Its ESG Profile
- Multiple ESG controversies plaguing Chemours have led to weaker returns compared to peers, with Environmental, Human Rights (Human Health), and Leadership & Governance being the key issues.
- 09/06/2021
|
Chemours Appoints Sandra Phillips Rogers to Board of Directors
- WILMINGTON, Del. , Sept. 1, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the appointment of Sandra Phillips Rogers to its board of directors.
- 09/01/2021
|
Here's Why You Should Add Chemours (CC) Stock to Your Portfolio
- Chemours (CC) benefits from increasing adoption of the Opteon platform and its actions to reduce costs.
- 08/30/2021
|
US Chemical Output Up in July on Continued Post-Storm Rebound
- The July reading showed higher production on a monthly comparison basis across all regions, reflecting sustained demand for chemical products.
- 08/26/2021
|
The Chemours Company: A 10.1x Forward P/E Multiple, Strong Portfolio And Dividend Yield Of 3.1% Make It A Buy
- CC offers a safe 3.1% starting dividend yield. The company is trading at a 10.1x forward P/E multiple assuming management's guidance is met.
- 08/23/2021
|
Chemours (CC) Up 25% in 6 Months: What's Driving the Stock?
- Chemours (CC) benefits from a recovery in demand on the global macroeconomic recovery and its cost-reduction actions.
- 08/23/2021
|
Chemours (CC) Wraps Up Senior Notes Offering of $650 Million
- Chemours (CC) plans to use the net proceeds to fund the purchase price as well as accrued and unpaid interest for any and all of its outstanding 7% senior notes due 2025.
- 08/19/2021
|
The Chemours Company Announces Completion of Private Offering of $650 Million Aggregate Principal Amount of 4.625% Senior Unsecured Notes Due 2029
- WILMINGTON, Del., Aug. 18, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced it has completed its previously announced private offering (the "offering") of $650 million in aggregate principal amount of 4.625% senior unsecured notes due 2029 that was exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").
- 08/18/2021
|
The Chemours Company Announces Early Tender Results of Conditional Cash Tender Offer and Consent Solicitation for Any and All of its 7.000% Senior Notes Maturing in 2025 and Receipt of Requisite Consents
- WILMINGTON, Del., Aug. 17, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the early tender results as of 5:00 p.m.
- 08/17/2021
|
Here's Why Chemours (CC) is a Strong Growth Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 08/12/2021
|
Chemours Announces Pricing of Private Offering of $650 Million Aggregate Principal Amount of 4.625% Senior Unsecured Notes Due 2029
- WILMINGTON, Del., Aug. 4, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the pricing of the previously announced private offering of $650 million in aggregate principal amount of 4.625% senior unsecured notes due 2029 that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").
- 08/04/2021
|
The Chemours Company Announces Conditional Redemption and Cash Tender Offer and Consent Solicitation for Any and All of Its 7.000% Senior Notes Maturing in 2025
- WILMINGTON, Del., Aug. 4, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced that it has commenced a tender offer (the "Tender Offer") to purchase for cash any and all of its outstanding 7.000% senior notes due 2025 (the "Notes").
- 08/04/2021
|
Top Ranked Growth Stocks to Buy for August 3rd
- BSET, CRI, BCOR, and CC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 3, 2021.
- 08/03/2021
|
The Chemours Company (CC) CEO Mark Vergnano on Q2 2021 Results - Earnings Call Transcript
- The Chemours Company (CC) CEO Mark Vergnano on Q2 2021 Results - Earnings Call Transcript
- 07/30/2021
|
Chemours' (CC) Q2 Earnings and Revenues Surpass Estimates
- Chemours (CC) delivers impressive second-quarter results, led by strong sales growth across all its units backed by global macroeconomic recovery.
- 07/30/2021
|
Chemours (CC) Q2 Earnings and Revenues Surpass Estimates
- Chemours (CC) delivered earnings and revenue surprises of 34.83% and 9.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Chemours Demonstrates Strong Progress on Sustainability Efforts in its Most Recent Corporate Responsibility Commitment Report
- WILMINGTON, Del., July 28, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, today announced strong progress towards achieving its long-term sustainability goals with the launch of its annual Corporate Responsibility Commitment (CRC) report.
- 07/28/2021
|
The Chemours Company Agrees to Sell Mining Solutions Business to Draslovka for $520 Million
- WILMINGTON, Del., July 26, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions has entered into a definitive agreement to sell its Mining Solutions business for $520 million in cash (representing 10 times 2020 Adjusted EBITDA)1 to Draslovka Holding a.s.
- 07/26/2021
|
Chemours (CC) to Report Q2 Earnings: What's in the Cards?
- Chemours' (CC) second-quarter results are likely to reflect increasing customer adoption of Opteon refrigerants as well as benefit from cost-cutting measures.
- 07/26/2021
|
The Chemicals Market Is Evolving and Growing: 8 Picks
- The chemical-diversified industry is poised to grow strongly over the next few years, so this is a great time to get some exposure.
- 07/21/2021
|
Chemours (CC) Breaks Ground on New Mining Facility in Florida
- Chemours (CC) expands mining projects in Florida, ensuring environmentally sustainable methods and job creation.
- 07/14/2021
|
Chemours breaks ground on $93 million mining facility in Clay County, Florida
- CLAY COUNTY, Fla., July 13, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, recently held a groundbreaking ceremony for a new $93 million mining facility on land leased from Camp Blanding in Clay County, Florida.
- 07/13/2021
|
Chemours Announces Dates for Second Quarter 2021 Earnings Release and Webcast Conference Call
- WILMINGTON, Del., July 12, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, announced it will release second quarter 2021 financial results after market close on Thursday, July 29, 2021.
- 07/12/2021
|
Energy Fuels and Neo Performance Materials Announce Contract Signing and Launch of Commercial Shipments of Rare Earth Product to Europe in Emerging U.S.-Based Rare Earth Supply Chain
- Physical shipment of commercial quantities of rare earths from Energy Fuels' White Mesa Mill in Utah to Neo Performance Materials' plant in Estonia represents an important milestone in creation of new rare earth supply chain TORONTO, ON and LAKEWOOD, Colo., July 7, 2021 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) ("Energy Fuels") and Neo Performance Materials Inc. (TSX: NEO) ("Neo") are pleased to announce that the first container (approximately 20 tonnes of product) of an expected 15 containers of mixed rare earth carbonate ("RE Carbonate") has been successfully produced by Energy Fuels at its White Mesa Mill in Utah (the "Mill") and is en route to Neo's rare earth separations facility in Estonia, creating a new United States-to-Europe rare earth supply chain.
- 07/07/2021
|
5 Top-Ranked Stocks Displaying High Earnings Yield
- Earnings yield is an important tool for investors with exposure to both stocks and bonds.
- 06/28/2021
|
Why You Should Add Chemours (CC) Stock to Your Portfolio Now
- Chemours (CC) benefits from increasing adoption of the Opteon platform and its efforts to reduce costs.
- 06/22/2021
|
Reddit Stocks: How to Become a Millionaire With Meme Investing
- There's no doubt that meme investing can be risky. But there is a way that taking some moonshots with Reddit stocks can work in your favor.
- 06/18/2021
|
UConn School of Engineering Unveils the Vergnano Institute for Inclusion, Supported by UConn Alumni Mark and Betsy Vergnano's $3M Donation
- STORRS, Conn., June 16, 2021 /PRNewswire/ -- The UConn School of Engineering today announced the creation of the Vergnano Institute for Inclusion, an endowed Institute funded by a generous gift from two UConn alumni, that will drive increased diversity, equity, and inclusion (DEI) within the engineering field by providing underrepresented students with access to scholarships, coaching and mentorship opportunities, training, and other critical career development resources within the School.
- 06/16/2021
|
The Chemours Company announces date for Advanced Performance Materials Investor Webinar
- WILMINGTON, Del., June 15, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions today announced that it will host an investor webinar on June 28 th, 2021 at 10 a.m.
- 06/15/2021
|
Are Investors Undervaluing Chemours (CC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/14/2021
|
Chemours Receives 2021 ACC Sustainability Leadership Award
- WILMINGTON, Del., June 9, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, was honored today by the American Chemistry Council (ACC) with the 2021 Sustainability Leadership Award in the Product Safety, Innovation, and Transparency category.
- 06/09/2021
|
Strong Demand, Manufacturing Upswing Buoy Chemicals: 5 Top Picks
- A strong revival in industrial demand and strengthening manufacturing activities are driving the upturn in the chemical industry. DOW, OLN, UNVR, WLK and CC are good options for investment right now.
- 06/08/2021
|
QYLD: 12% Yield On The Nasdaq 100, Pays Monthly
- QYLD: 12% Yield On The Nasdaq 100, Pays Monthly
- 06/04/2021
|
Chemours (CC) Stock Hits 52-Week High: What's Driving It?
- Chemours (CC) is gaining from higher demand for Opteon in mobile applications and cost-cutting measures.
- 06/03/2021
|
Chemours' (CC) Opteon XL41 Selected by Johnson Controls
- Chemours (CC) has been selected by Johnson Controls to provide Opteon XL41 for the latter's HVAC products to facilitate the phase out of high GWP options.
- 06/01/2021
|
Chemours Company: A Decent Prospect
- Chemours Company has had rather depressing financial results over the past few years leading up to the present day.
- 05/28/2021
|
Johnson Controls Selects Opteon™ XL41 (R-454B) as Future Refrigerant Solution to Replace R-410A in North America
- WILMINGTON, Del., May 27, 2021 /PRNewswire/ -- The Chemours Company has been selected by Johnson Controls, the global leader in smart, healthy and sustainable buildings, to provide Opteon™ XL41 (R-454B) as the future refrigerant solution for their ducted residential and commercial HVAC products, as well as its air-cooled scroll chiller applications.
- 05/27/2021
|
Here's Why Chemours (CC) is a Great Momentum Stock to Buy
- Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 05/27/2021
|
Book Profits by Investing in These High Earnings Yield Picks
- Invest in high earnings yield stocks like PBR, HIMX, TEN and CC for sturdy gains.
- 05/26/2021
|
Chemours Can Leverage Its Leadership Position Against A Favorable Backdrop, BofA Says
- Chemours Co (NYSE: CC) is attractively positioned with titanium dioxide pigments (TiO2) prices inflecting and governments aiming to phase out legacy refrigerant technology, according to BofA Securities. The Chemours Analyst: Matthew DeYoe initiated coverage of Chemours with a Buy rating and a price target of $42.
- 05/20/2021
|
Merck, Micron, Nvidia, Target and More Thursday Afternoon Analyst Calls
- With the trading day almost halfway over, the markets had made a handy recovery on Thursday, bouncing off the lows of last week.
- 05/20/2021
|
How to Take Advantage of Chemours Stock's Dip
- Chemical concern Chemours Co (NYSE:CC) took a trip to the earnings confessional on May 3, reporting first-quarter earnings and revenue that were well above Wall Street's forecasts, leading the company to raise its full-year guidance.
- 05/19/2021
|
Chemours to Supply Lower GWP Refrigerant to Three Ice Rink Venues in Beijing
- BEIJING, May 18, 2021 /PRNewswire/ -- The Chemours Company has achieved a Memorandum of Understanding (MoU) with the Beijing National Aquatics Center, Beijing National Indoor Stadium and Wukesong Sports Centre for use of Opteon™ lower global warming potential (GWP) refrigerants at the three venues. Participating in the MoU signing ceremony were Ms.
- 05/18/2021
|
Chemours Supports Local Community with Sustainable, Low-GWP Opteon™ XP10 Refrigerant
- WILMINGTON, Del., May 12, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, was recently recognized for its donation to an innovative, sustainable refrigeration system installed in Gem City Market - a newly opened community co-op that supports the elimination of a food desert in downtown Dayton, Ohio.
- 05/12/2021
|
Should Value Investors Buy Chemours (CC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/12/2021
|
More Than $7 Million Raised in Inaugural Year of Chemical Industry's Equity, Diversity & Inclusion Initiative
- WASHINGTON, May 11, 2021 /PRNewswire/ -- With the support of 43 chemical manufacturers and related industry stakeholders, the founding partners of the Future of STEM Scholars Initiative (FOSSI) today announced the program surpassed its 2021 goal to fund scholarships for 150 students majoring in science, technology, engineering, and math (STEM) at Historically Black Colleges and Universities (HBCUs). The program will support 151 scholars in its inaugural year, at an investment of $7.2 million dollars.
- 05/11/2021
|
Chemours (CC) Earnings and Revenues Beat Estimates in Q1
- Chemours' (CC) Q1 results benefit from higher sales in Titanium Technologies and Advanced Performance Materials units driven by demand recovery.
- 05/05/2021
|
Chemours Co (CC) CEO Mark Vergnano on Q1 2021 Results - Earnings Call Transcript
- Chemours Co (CC) CEO Mark Vergnano on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
Chemours (CC) Surpasses Q1 Earnings and Revenue Estimates
- Chemours (CC) delivered earnings and revenue surprises of 4.41% and 3.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/03/2021
|
Chemours stock rises 1% after better-than-expected Q1 adjusted profit
- Chemours Co. stock rose 1% in the extended session Monday after the maker of Teflon and other compounds reported a mixed fiscal 2020 first quarter and said it was reducing costs and capital expenditures. Chemours said it earned $100 million, or 61 cents a share, in the quarter, compared with 55 cents a share in the fiscal 2019 first quarter.
- 05/03/2021
|
The Chemours Company Reports Strong First Quarter Results and Increases Full-Year 2021 Outlook
- WILMINGTON, Del., May 3, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions today announces its financial results for the first quarter 2021.
- 05/03/2021
|
Chemours's Earnings Outlook
- On Monday, May 03, Chemours (NYSE:CC) will release its latest earnings report. Decipher the announcement with Benzinga's help.
- 04/30/2021
|
San Jose Sharks Successfully Install Opteon™ Refrigerant in New Ice Refrigeration Systems at SAP Center at San Jose
- WILMINGTON, Del., April 29, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, today announced the successful installation and use of Opteon™ refrigerant at SAP Center at San Jose, home of the San Jose Sharks® in California.
- 04/29/2021
|
Chemours Announces Investment in Family Forests Program
- WILMINGTON, Del., April 22, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced a partnership with the American Forest Foundation (AFF) to preserve and enhance family-owned forest lands in West Virginia to help combat climate change.
- 04/22/2021
|
Chemours Announces Ambitious Net Zero Greenhouse Gas Emissions Goal
- WILMINGTON, Del., April 15, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, today announced its ambitious goal to achieve net zero greenhouse gas emissions by 2050.
- 04/15/2021
|
Chemours Announces Dates for First Quarter 2021 Earnings Release and Webcast Conference Call
- WILMINGTON, Del., April 13, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, announced it will release first quarter 2021 financial results after market close on Monday, May 3, 2021.
- 04/13/2021
|
Materials And VAW Dashboard For April
- Materials And VAW Dashboard For April
- 04/12/2021
|
Chemours mulls over selling its mining business
- Shares of Chemours Co. rose nearly 2% in the extended session Monday after the chemical company said it has started a review to assess its mining business, including a potential sale. "The process is intended to drive shareholder value and portfolio focus," Chemours said.
- 03/22/2021
|
Chemours Announces Strategic Review of Mining Solutions Business
- WILMINGTON, Del., March 22, 2021 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company with leading positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials and Chemical Solutions, today announced the next step in its growth and repositioning journey.
- 03/22/2021
|
Why This Little-Known Stock Shot Up 19.5% and Hit a 52-Week High in February
- Tronox Holdings is making the most of a strong recovery in a key end market.
- 03/08/2021
|
Chemours: 15% Below Lowest Price Target, High Options Yields
- Chemours gained 41% in 2020 but has retraced -16% since its Q4 '20 earnings report. It yields 4.2%/year, but its options have much higher yields of 7.5% to 9.5% in under four months.
- 02/27/2021
|
Top Stocks To Short Today As Inflation Fears Cause Indices To Retreat
- The major indices are broadly in the red right now, but the deep learning algorithms at Q.ai have assessed the market to give you today's top shorts.
- 02/17/2021
|
The Chemours Company (CC) CEO Mark Vergnano on Q4 2020 Results - Earnings Call Transcript
- The Chemours Company (CC) CEO Mark Vergnano on Q4 2020 Results - Earnings Call Transcript
- 02/12/2021
|
Chemours (CC) Tops Earnings and Revenue Estimates in Q4
- Chemours' (CC) fourth-quarter performance benefits from a global macroeconomic recovery.
- 02/12/2021
|
Chemours stock jumps 5% as Q4 sales nearly back at pre-pandemic levels
- Shares of Chemours Co. rose nearly 5% in the extended session Thursday after the maker of Teflon and other compounds swung to a fourth-quarter profit and reported quarterly sales in line with Wall Street expectations. Chemours said it earned $19 million, or 11 cents a share, in the quarter, versus a loss of $317 million in the year-ago quarter.
- 02/11/2021
|
3 Long-Term Payers Announce Dividends
- The Chemours Co (NYSE:CC), IF Bancorp Inc (NASDAQ:IROQ) and Equinix Inc (NASDAQ:EQIX) all announced dividends on Wednesday, Feb. 10.
- 02/11/2021
|
Chemours (CC) to Post Q4 Earnings: What's in the Cards?
- Chemours' (CC) fourth-quarter 2020 results are likely to reflect recovery in demand across all markets and regions as well as benefits from cost-cutting measures.
- 02/09/2021
|
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
- Is (CC) Outperforming Other Basic Materials Stocks This Year?
- 02/03/2021
|
Chemours (CC) Gains As Market Dips: What You Should Know
- Chemours (CC) closed the most recent trading day at $27.28, moving +1.83% from the previous trading session.
- 01/27/2021
|
Should Value Investors Buy Chemours (CC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/25/2021
|
DuPont, Corteva and Chemours settle PFAS legal disputes, with expenses capped at $4 billion
- DuPont de Nemours Inc. , Corteva Inc. and Chemours Co. announced Friday an agreement to settle legal disputes, and to establish a cost-sharing arrangement related to PFAS liabilities. Under terms of the agreement, expenses will be split 50-50, with DuPont and Corteva responsible for one half and Chemours responsible for the other half.
- 01/22/2021
|
DuPont, Corteva, and Chemours announce resolution of legacy PFAS claims
- WILMINGTON, Del., Jan. 22, 2021 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating...
- 01/22/2021
|
Is The Chemours (CC) Outperforming Other Basic Materials Stocks This Year?
- Is (CC) Outperforming Other Basic Materials Stocks This Year?
- 01/18/2021
|
Wall Street Unfazed by Lingering Unease in Washington: 5 Picks
- Expectations about stimulus package, Fed's supportive stance, and vaccine rollout have helped investors remain optimistic, which calls for investing in growth stocks like D.R. Horton (DHI) and DocuSign (DOCU).
- 01/14/2021
|
3 Reasons Why Chemours (CC) Is a Great Growth Stock
- Chemours (CC) possesses solid growth attributes, which could help it handily outperform the market.
- 01/13/2021
|
Is Chemours (CC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/08/2021
|
Chemours (CC) Stock Rallies 79% in 6 Months: What's Driving It?
- Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown, strong execution and its cost-reduction measures.
- 01/07/2021
|
6 Stocks Trading Near 52-Week Highs That Can Appreciate Further
- Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
- 01/07/2021
|
Global Chemical Output Leaps for Sixth Straight Month: 5 Picks
- The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's recovery.
- 01/06/2021
|
Chemours is Prepared to Support US Industry with Pivotal Next Generation, Low Global Warming Potential Technologies
- WILMINGTON, Del., Jan. 5, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Fluoroproducts and Chemical Solutions, applauds the 116th Congress in its recent passing of the bipartisan American...
- 01/05/2021
|
5 Chemical Stocks Poised to Maintain Winning Streak in 2021
- A rebound in China, demand upturn across major markets and recovering manufacturing activities augur well for the chemical industry heading into 2021.
- 12/29/2020
|
4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
- 4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
- 12/28/2020
|
What Makes Chemours (CC) Stock a Solid Choice Right Now
- Chemours (CC) benefits from demand recovery, cost-management initiatives and strong execution.
- 12/28/2020
|
Is Chemours Company (CC) a Good Value Investor Stock Now?
- Let's see if The Chemours Company (CC) stock is a good choice for value-oriented investors right now from multiple angles.
- 12/22/2020
|
Chemours: Outperforming In 2020, Estimates Rising
- CC has received multiple upward earnings revisions from analysts over the past month. CC has very attractive 10% - 12% options yields, which are detailed at the end of this article.
- 12/07/2020
|
The Chemours Company Announces Completion of Private Offering of $800 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2028
- WILMINGTON, Del., Nov. 27, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced it had completed its previously announced private...
- 11/27/2020
|
The Chemours Company Announces Early Tender Results Of Conditional Cash Tender Offer And Consent Solicitation For Any And All Of Its 6.625% Senior Notes Maturing In 2023 And Receipt Of Requisite Consents
- WILMINGTON, Del., Nov. 25, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced the early tender results as of 5:00 p.m., New York City...
- 11/25/2020
|
Chemours Announces Pricing Of Private Offering Of $800 Million Aggregate Principal Amount Of 5.750% Senior Unsecured Notes Due 2028
- WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced the pricing of the previously announced private offering...
- 11/12/2020
|
The Chemours Company (CC) CEO Mark Vergnano on Q3 2020 Results - Earnings Call Transcript
- The Chemours Company (CC) CEO Mark Vergnano on Q3 2020 Results - Earnings Call Transcript
- 11/04/2020
|
Miller Value Partners is Bullish on The Chemours Company (CC) Stock
- Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. In the third quarter, the Miller Income Strategy fund returned 7.89% versus 4.71% for the ICE BofA Merrill Lynch High Yield Index. You should check out Miller Value Partners' top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
- 11/03/2020
|
Chemours Announces Fourth Quarter Dividend
- WILMINGTON, Del., Oct. 28, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a...
- 10/28/2020
|
Don’t Be Afraid to Wear Fringe This Fall
- Free-floating layers add an unexpected feeling of delight and drama to decorous dressing
- 10/11/2020
|
Durable Medical Equipment Market Competitive Status, Threat, Restraints and Industry Summary | Medtronic Inc, Stryker Corporation
- Oct 09, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as Durable Medical Equipment Market. It...
- 10/09/2020
|
Blowing Agents Market by Type, Foam, and Region - Global Forecast to 2025 - ResearchAndMarkets.com
|
Rapid Application Development Market Future Growth and Present Status | International Business Machines Corporation, Intel Corporation
- Oct 08, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as Rapid Application Development...
- 10/08/2020
|
Smartphone's Market Demand, Revenue, Threat, Growth and Product Analysis | Samsung Electronics Co Ltd, Apple Inc
- Oct 08, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as Smartphone’s Market. It is a...
- 10/08/2020
|
Stainless Steel Foil Market Restraints, Segmentation, Analysis, Opportunities and Growth Forecast | Nippon Steel & Sumitomo Metal Corporation, Ulbrich Stainless Steels & Special Metals Inc
- Oct 08, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as Stainless Steel Foil Market. It is a...
- 10/08/2020
|
building panels market Market Prominent Growth, Striking Opportunities Scenario and Technological Advancement | Nippon Steel & Sumitomo Metal Corporation, Panasonic Corporation
- Oct 08, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as building panels market Market. It is...
- 10/08/2020
|
COVID-19 Recovery Analysis: Global Titanium Dioxide Market | Increasing Use of Titanium Dioxide as Absorbent of Pollutants to Boost Market Growth | Technavio
- The Global Titanium Dioxide Market will grow by 1194.22 th tons during 2020-2024
- 10/07/2020
|
Canada Pension Plan Investment Board Trims Stock Position in Chemours Co (NYSE:CC)
- Canada Pension Plan Investment Board lowered its stake in shares of Chemours Co (NYSE:CC) by 89.8% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 12,100 shares of the specialty chemicals company’s stock after selling 107,045 shares during the period. Canada Pension Plan Investment Board’s holdings in […]
- 09/24/2020
|
TiO2 Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
- The TiO2 market will register an incremental spend of about $7 billion, growing at a CAGR of 7.14% during the five-year forecast period.
- 09/16/2020
|
The Chemours Company: Mixed Short-Term Outlook
- CC has outperformed the peers YTD. The trade war and the coronavirus have taken their toll on CC's revenues in 2019 and 2020.
- 09/07/2020
|
Concentrated Nitric Acid: World Market Outlook 2020-2025 - ResearchAndMarkets.com
|
Tracking David Einhorn's Portfolio - Q2 2020 Update
- David Einhorn's 13F stock portfolio value increased from $702M to $922M this quarter. Greenlight added Vaneck Gold Miners ETF and Atlas Air Worldwide while dropping Altice USA and Adient plc.
- 08/25/2020
|
Einhorn Tells Investors: Tesla Is Gaming S&P 500 Index Committee
- The Federal Reserve has poured unprecedented levels of stimulus into the U.S. economy to deal with the pandemic, and most experts agree that inflation is just around the corner. David Einhorn has positioned his Greenlight Capital to benefit from inflation when it arrives. Preparing for inflation In his second-quarter letter to investors, which was reviewed by ValueWalk, […]
- 08/15/2020
|
Einhorn Tells Investors Tesla Is Gaming S&P 500 Index Committee
- The guru also said the company has been 'abusing its stakeholders' so much that he could write pages about it every quarter Continue reading...
- 08/14/2020
|
Bill Miller is Betting on Chemours Co (CC) Stock
- Miller Value Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here. In the second quarter, the Miller Income Strategy fund returned 21.7% versus 9.6% for the unmanaged benchmark. You should check out Miller Value Partners' top 5 stock picks for investors to buy right now, which could be […]
- 08/14/2020
|
The Chemours (CC) Presents At 2020 Energy, Industrials & Airlines Virtual Conference - Slideshow
- The following slide deck was published by The Chemours Company in conjunction with this event.
- 08/14/2020
|
The Chemours Company (NYSE:CC) Goes Ex-Dividend Soon
- The Chemours Company (NYSE:CC) stock is about to trade ex-dividend in 4 days. You will need to purchase shares before...
- 08/09/2020
|
Read This Before Considering The Chemours Company (NYSE:CC) For Its Upcoming US$0.25 Dividend
- It looks like The Chemours Company (NYSE:CC) is about to go ex-dividend in the next 4 days. If you purchase the stock...
- 08/09/2020
|
Greenlight Capital Re, Ltd. (GLRE) CEO Simon Burton on Q2 2020 Results - Earnings Call Transcript
- Greenlight Capital Re, Ltd. (NASDAQ:GLRE) Q2 2020 Earnings Conference Call August 6, 2020 10:00 AM ET Company Participants Simon Burton - Chief Executive Officer David Einhorn - Chairman Tim Courtis - Chief Financial Officer Conference Call Participants Mikel Abasolo - Solo Capital Management Presentation Operator Good day and thank you for joining the Greenlight Re Conference Call for the Second Quarter of 2020 Earnings.
- 08/09/2020
|
Insights on the Global Glycolic Acid Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
- The Global Glycolic Acid Market will grow by USD 194.72 mn during 2020-2024
- 08/07/2020
|
How Much Of The Chemours Company (NYSE:CC) Do Institutions Own?
- A look at the shareholders of The Chemours Company (NYSE:CC) can tell us which group is most powerful. Institutions...
- 08/06/2020
|
2 Gurus Have Contrasting Views on the Economy and Market
- David Einhorn and Seth Klarman do not agree on the expected performance in the coming months Continue reading...
- 08/05/2020
|
Chemours Co (NYSE:CC) Shares Sold by Creative Planning
- Creative Planning decreased its stake in shares of Chemours Co (NYSE:CC) by 13.2% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 13,971 shares of the specialty chemicals company’s stock after selling 2,132 shares during the quarter. Creative Planning’s holdings in Chemours were worth $214,000 as of its most recent SEC filing. Several other hedge […]
- 08/05/2020
|
The Chemours Company (CC) Q2 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to The Chemours Company Second Quarter Earnings Call. Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operations and the other risks and uncertainties described in the documents Chemours has filed with the SEC.
- 07/31/2020
|
Chemours (CC) Earnings and Revenues Surpass Estimates in Q2
- Chemours' (CC) revenues hurt by lower volumes across all segments in the second quarter.
- 07/31/2020
|
The Chemours Company (CC) CEO Mark Vergnano on Q2 2020 Results - Earnings Call Transcript
- The Chemours Company (NYSE:CC) Q2 2020 Earnings Conference Call July 31, 2020, 08:30 AM ET Company Participants Jonathan Lock - Vice President, Corporate Development and Investor Relations Mark Vergnano - President and Chief Executive Officer Mark Newman - Senior Vice President and Chief Operating Officer Sameer Ralhan - Senior Vice President and Chief Financial Officer Conference Call Participants John McNulty - BMO Capital Markets Duffy Fischer - Barclays Bob Koort - Goldman Sachs Josh Spector - UBS Laurence Alexander - Jefferies Arun Viswanathan - RBC Capital Markets P.J.
- 07/31/2020
|
The Chemours Company 2020 Q2 - Results - Earnings Call Presentation
- The following slide deck was published by The Chemours Company in conjunction with their 2020 Q2 earnings call.
- 07/31/2020
|
Chemours (CC) Q2 Earnings and Revenues Beat Estimates
- Chemours (CC) delivered earnings and revenue surprises of 100.00% and 1.44%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2020
|
Chemours Announces Third Quarter Dividend
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the third quarter of 2020. The dividend will be paid on September 15, 2020 to stockholders of record as of the close of business on August 17, 2020.
- 07/29/2020
|
Miller Value Partners Income Strategy 2Q 2020 Letter
- Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term.
- 07/29/2020
|
Why Chemours (CC) Could Beat Earnings Estimates Again
- Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/27/2020
|
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/23/2020
|
Shareholder Alert: Robbins LLP is Investigating The Chemours Company (CC) on Behalf of Shareholders
- Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of The Chemours Company (NYSE: CC) for breaches of fiduciary duty and violations of the Securities and Exchange Act of 1934. Chemours, a spin-off from DuPont, provides a wide range of industrial and specialty chemicals products for various markets and has a long history of using of perfluoroalkyl and polyfluoroalkyl substances ("PFAS").
- 07/22/2020
|
APG Asset Management N.V. Cuts Stock Holdings in Chemours Co (NYSE:CC)
- APG Asset Management N.V. trimmed its position in shares of Chemours Co (NYSE:CC) by 97.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,800 shares of the specialty chemicals company’s stock after selling 744,060 shares during the quarter. APG Asset Management N.V.’s holdings […]
- 07/15/2020
|
Chemours Announces 2020 Future of Chemistry Scholarship Recipients and Expands the Program Nationally
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, today awarded scholarships to five Delaware students pursuing degrees in science, technology, engineering, or mathematics (STEM) at Historically Black Colleges and Universities (HBCUs). In partnership with the City of Wilmington and HBCU Week, these scholarships are part of a 13-year commitment—through 2030—to support increased numbers of Black students from the Wilmington area who are pursuing STEM fields of study. This year Chemours took that commitment even further by expanding the scholarship program to all its US sites. Consistent with the company's broader Corporate Responsibility Commitments which includes goals on increased diversity, the Future of Chemistry Scholarship program exists to increase access and opportunities for students from underrepresented populations to pursue STEM and technical careers. Over the next decade, Chemours has committed to awarding more than $2 million in scholarships to students attending HBCUs.
- 07/13/2020
|
Did Hedge Funds Make The Right Call On The Chemours Company (CC) ?
- We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
- 07/11/2020
|
Chemours Announces Dates for Second Quarter 2020 Earnings Release and Webcast Conference Call
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced it will release second quarter 2020 financial results after market close on Thursday, July 30, 2020. The company will conduct its second quarter 2020 webcast conference call on Friday, July 31, 2020 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.
- 07/10/2020
|
Should Investors Buy the Dip in Chemours (CC) Stock?
- If you are looking for the best ideas for your portfolio you may want to consider some of Greenlight Capital's top stock picks. Greenlight Capital, an investment management firm, is bullish on Chemours Co (NYSE:CC) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its investment […]
- 07/08/2020
|
Chemours Co to Post Q2 2020 Earnings of $0.20 Per Share, Jefferies Financial Group Forecasts (NYSE:CC)
- Chemours Co (NYSE:CC) – Jefferies Financial Group upped their Q2 2020 earnings estimates for shares of Chemours in a research note issued on Wednesday, June 24th. Jefferies Financial Group analyst L. Alexander now anticipates that the specialty chemicals company will earn $0.20 per share for the quarter, up from their prior forecast of ($0.01). Jefferies […]
- 07/01/2020
|
Legal & General Group Plc Has $2.48 Million Stock Position in Chemours Co (NYSE:CC)
- Legal & General Group Plc boosted its holdings in shares of Chemours Co (NYSE:CC) by 4.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 279,038 shares of the specialty chemicals company’s stock after buying an additional 11,886 shares during the period. Legal & General […]
- 06/27/2020
|
Chemours Gets EPA Nod for Glyclean Cleaner for Coronavirus
- Chemours (CC) is working closely with customers to ensure that it offers products required for slowing and limiting the spread of the coronavirus.
- 06/26/2020
|
Chemours Co Forecasted to Earn Q3 2020 Earnings of $0.33 Per Share (NYSE:CC)
- Chemours Co (NYSE:CC) – Investment analysts at SunTrust Banks dropped their Q3 2020 EPS estimates for Chemours in a research note issued to investors on Tuesday, June 23rd. SunTrust Banks analyst J. Sheehan now expects that the specialty chemicals company will post earnings per share of $0.33 for the quarter, down from their previous estimate […]
- 06/26/2020
|
U.S. Environmental Protection Agency Approves Glyclean™ Hard Surface Cleaner as an Effective Disinfectant Against the Virus that Causes COVID-19
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the U.S. Environmental Protection Agency (EPA), has approved Glyclean™ Hard Surface Cleaner for use against SARS-COV-2, the virus that causes COVID-19. When Glyclean AM is formulated at appropriate concentrations into cleaning and disinfecting products, they too can be effective against the SARS-COV-2 virus and help prevent the spread of the novel coronavirus.
- 06/23/2020
|
Balyasny Asset Management LLC Makes New Investment in Chemours Co (NYSE:CC)
- Balyasny Asset Management LLC acquired a new position in shares of Chemours Co (NYSE:CC) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 127,482 shares of the specialty chemicals company’s stock, valued at approximately $1,131,000. Balyasny Asset Management LLC owned about 0.08% of […]
- 06/22/2020
|
Mackenzie Financial Corp Reduces Stake in Chemours Co (NYSE:CC)
- Mackenzie Financial Corp reduced its position in Chemours Co (NYSE:CC) by 7.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,534 shares of the specialty chemicals company’s stock after selling 1,900 shares during the period. Mackenzie Financial Corp’s holdings in […]
- 06/22/2020
|
APG Asset Management N.V. Cuts Stock Position in Chemours Co (NYSE:CC)
- APG Asset Management N.V. lowered its holdings in Chemours Co (NYSE:CC) by 97.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,800 shares of the specialty chemicals company’s stock after selling 744,060 shares during the period. APG Asset Management N.V.’s holdings […]
- 06/19/2020
|
Principal Financial Group Inc. Sells 402,965 Shares of Chemours Co (NYSE:CC)
- Principal Financial Group Inc. cut its stake in Chemours Co (NYSE:CC) by 44.4% during the 1st quarter, HoldingsChannel.com reports. The fund owned 505,409 shares of the specialty chemicals company’s stock after selling 402,965 shares during the period. Principal Financial Group Inc.’s holdings in Chemours were worth $4,483,000 at the end of the most recent quarter. […]
- 06/16/2020
|
Chemours Co (NYSE:CC) Shares Purchased by Treasurer of the State of North Carolina
- Treasurer of the State of North Carolina increased its stake in shares of Chemours Co (NYSE:CC) by 71.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 67,454 shares of the specialty chemicals company’s stock after purchasing an additional 28,030 shares […]
- 06/15/2020
|
Buy Chemours Co (CC) Stock for Massive Upside Ahead
- Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P; 500 Index which returned -19.6% in the same quarter. You should check out Miller […]
- 06/11/2020
|
Patent Filings Roundup: WSOU Entity Leads Sustained Spike in District Court Filings, Sandoz Takes a Shot at Novo Nordisk’s Insulin treatment
- District court filings remained unusually high this week (97), with 40 Patent Trial and Appeal Board (PTAB) cases filed (one Covered Business Method, one Post Grant Review, and 38 Inter Partes Reviews).
- 06/10/2020
|
State Street Corp Buys 64,500 Shares of Chemours Co (NYSE:CC)
- State Street Corp lifted its holdings in Chemours Co (NYSE:CC) by 1.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,023,131 shares of the specialty chemicals company’s stock after buying an additional 64,500 shares during the period. State Street Corp’s […]
- 06/10/2020
|
Hedge Funds Getting Bullish On The Chemours Company (CC)
- Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- 06/05/2020
|
Why Is Chemours (CC) Up 20.1% Since Last Earnings Report?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/04/2020
|
Fluoropolymer Films Market Share 2020 to 2026 Status and Trend by Companies, Regional Outlook
- May 24, 2020 (Market Insight Reports) --
Selbyville, Delaware the newly Added research report at Market Study Report titled "2020-2026 Global Fluoropolymer...
- 05/24/2020
|
Greenlight Capital Exits General Motors, Cuts Chemours
- Firm's largest sales of the 1st quarter Continue reading...
- 05/22/2020
|
Baron & Budd Files Suit on Behalf of North Carolina Residents to Hold DuPont Responsible for Contaminating the Water Supply
- Today, the nationally recognized attorneys from Baron & Budd announced they have filed a lawsuit on behalf of over 200 North Carolina residents ag
- 05/20/2020
|
Report: Chemical firm Chemours won't face federal charges
- RALEIGH, N.C. (AP) - Federal prosecutors have declined to pursue criminal charges against a chemical company that for years discharged compounds with health risks that aren't fully understood into a North Carolina river, the company disclosed.
The U.S. Attorney's Office and the Environmental Natural Resources Division of the U.S. Justice Department were investigating potential violations of the federal Clean Water Act by The Chemours Co., a spinoff of DuPont that has a plant near Fayetteville, WRAL-TV reported.
In 2017, it was found that Chemours was releasing a compound called GenX into the air and water near the plant, which eventually made it into drinking water sources including the Cape Fear River. GenX is a chemical used in nonstick surfaces such as Teflon. The EPA classifies it as an "emerging contaminant" needing research, but has previously said animal studies suggest it can affect organs.
Chemours Co. told shareholders in a Securities and Exchange Commission filing released this month that prosecutors notified the company in March they were declining to pursue charges and were closing the case.
Chemours said that during the course of the review, it met with prosecutors, responded to subpoenas and sent witnesses to testify before a grand jury and to be interviewed by government investigators.
The company has also faced lawsuits and a state investigation. In a consent order with North Carolina in 2018, it agreed to pay a $12 million penalty and $1 million for investigative costs, and to sharply reduce air emissions of GenX. The company also agreed at the time to conduct studies of the health risks posed by releases into the environment of GenX and other per- and polyfluoroalkyl substances, or PFAS.
The EPA also said last year it would create a plan to help communities with monitoring and detecting...
- 05/19/2020
|
E.I. du Pont de Nemours and Company -- Moody's rates E.I. du Pont de Nemours and Company's (Corteva's) new notes A3
- Moody's Investors Service, ("Moody's") assigned A3 ratings to E.I. du Pont de Nemours and Company's (EID's) proposed senior unsecured notes. Roughly half of the proceeds from the debt issuance are expected to be used to prepay a portion of the company's unfunded pension liability, leaving the company's gross adjusted leverage unchanged for this portion of the issuance, with the balance of proceeds held in cash to shore up liquidity and serving as an offset to seasonal working capital needs, which tend to be very large and peak at about $4.0 billion. The outlook on the ratings is stable.
- 05/12/2020
|
McIntyre Partnerships 1Q20 Commentary: Long Chemours [Analysis]
- McIntyre Partnerships commentary for the first quarter ended March 31, 2020, discussing how the current crisis will likely impact Chemours (NYSE:CC)’s near-term earnings. Performance Review - FY 2019 Through Q1 2020, McIntyre Partnerships returned approx. -56% gross and net. This compares to S&P; 500, S&P; 600, and Russell 2000 returns including dividends of -20%, -33%, […]
- 05/11/2020
|
Venator Materials' (VNTR) CEO Simon Turner on Q1 2020 Results - Earnings Call Transcript
- Venator Materials PLC (NYSE:VNTR) Q1 2020 Earnings Conference Call May 06, 2020 10:00 AM ET Company Participants Jeffrey Schnell – Director-Investor Relations S
- 05/08/2020
|
The Chemours Company Just Beat EPS By 39%: Here's What Analysts Think Will Happen Next
- It's been a good week for The Chemours Company (NYSE:CC) shareholders, because the company has just released its...
- 05/08/2020
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
- Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGHLIGHTS
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Lyft Inc : Piper Sandler cuts to neutral from overweight
* Natera Inc : JP Morgan raises to overweight from neutral
* Occidental Petroleum Corp : SunTrust Robinson raises to hold from sell
* Solaredge Technologies : Canaccord Genuity cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.
* A. O. Smith Corp : Stephens raises target price to $40 from $37
* Acadia Healthcare Company Inc : Citigroup cuts price target to $34 from $37
* Acadia Healthcare Company Inc : Deutsche Bank cuts target price to $28 from $32
* Activision Blizzard Inc : Keybanc raises target price to $80 from $68
* Adient Plc : Deutsche Bank raises target price to $20 from $15
* ADMA Biologics Inc : Oppenheimer cuts target price to $7 from $14
* Advanced Energy Industries Inc : Citigroup raises price target to $63 from $40
* Advanced Energy Industries Inc : Cowen and Company raises PT to $58 from $51
* Advanced Energy Industries Inc : D.A. Davidson raises target to $60 from $50
* Advanced Energy Industries Inc : Susquehanna cuts target price to $85 from $90
* Aerie Pharmaceuticals Inc : H.C. Wainwright cuts target price to $31 from $37
* Aerie Pharmaceuticals Inc : Mizuho cuts target price to $29 from $34
* Aerie Pharmaceuticals Inc : Piper Sandler cuts target price to $35 from $45
* Aerie Pharmaceuticals Inc : SunTrust Robinson cuts price target to $22 from $26
* Agco Corp : Stephens raises target price to $65 from $60
* Air Transport Services Group Inc : Cowen and Company raises PT to $26 from $25
* Albemarle Corp : UBS cuts target price to $90 from $98
* Alexion Pharmaceuticals Inc : BMO cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Credit Suisse cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Jefferies cuts price target to $111 from $112
* Alexion Pharmaceuticals Inc : Raymond James cuts target price to $156 from $159
* Alexion Pharmaceuticals Inc : SunTrust Robinson cuts target to $135 from $141
* Alexion Pharmaceuticals Inc : SVB Leerink cuts target price to $150 from $156
* Allegiant Travel Co : Cowen and Company cuts price target to $74 from $100
* Allete Inc : Guggenheim cuts price target to $65 from $70
* Allogene Therapeutics Inc : Jefferies raises target price to $37 from $36
* Allstate Corp : Piper Sandler raises target price to $112 from $108
* Alnylam Pharmaceuticals Inc : Guggenheim raises price target to $166 from $155
* Alnylam Pharmaceuticals Inc : BMO raises target price to $171 from $145
* Alnylam Pharmaceuticals Inc : Jefferies raises price target to $165 from $142
* Alnylam Pharmaceuticals Inc : JP Morgan cuts to neutral from overweight
* Alnylam Pharmaceuticals Inc : JP Morgan raises target price to $137 from $133
* Alnylam Pharmaceuticals Inc : Needham raises target price to $160 from $135
* Alnylam Pharmaceuticals Inc : Oppenheimer raises target price to $162 from $140
* Alnylam Pharmaceuticals Inc : Piper Sandler raises target to $169 from $142
* Alteryx Inc : Citigroup cuts price target to $147 from $160
* Alteryx Inc : Cowen and Company cuts target price to $135 from $145
* Alteryx Inc : Needham cuts target price to $140 from $152
* Alteryx Inc : Wedbush cuts price target to $138 from $146
* Amedisys Inc : Benchmark cuts to hold rating
* Ameriprise Financial Inc : Evercore ISI raises target price to $139 from $136
* Ametek Inc : Berenberg raises target price to $93 from $86
* Ametek Inc : Stephens cuts target price to $92 from $94
* Anaptysbio Inc : Credit Suisse raises target price to $16 from $14
* Apache Corp : Credit Suisse raises target price to $10 from $4
* Aptiv Plc : Deutsche Bank raises target price to $75 from $59
* Arcus Biosciences Inc : Wedbush raises target price to $40 from $26
* Ares Capital Corp : BMO cuts target price by $5 to $16
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Ares Management Corp : BMO raises target price to $40 from $30
* Ares Management Corp : Credit Suisse raises target price to $40 from $38
* Ares Management Corp : Jefferies raises target price to $42 from $39
* Ares Management Corp : KBW raises target price to $45 from $44
* ASGN Inc : Jefferies raises target price to $54 from $31
* Ashland Global Holdings Inc : Deutsche Bank raises target price to $70 from $65
* Ashland Global Holdings Inc. : JP Morgan cuts target price to $62 from $68
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Ashland Global Holdings Inc. : SunTrust Robinson cuts price target to $75 from $87
* Aspen Technology Inc : Benchmark cuts target price to $130
* Aspen Technology Inc : Keybanc raises target price to $120 from $110
* Assetmark Financial Holdings Inc : BMO cuts target price to $23 from $26
* Assurant Inc : SunTrust Robinson cuts price target to $145 from $155
* Astronics Corp : Canaccord Genuity cuts target price to $10 from $14
* Astronics Corp : SunTrust Robinson cuts price target to $6 from $7
* Atkore International Group Inc : Citigroup raises price target to $26 from $24
* Atlas Corp (British Columbia) : Citigroup cuts price target to $7 from $12
* Avanos Medical Inc : Berenberg raises target price to $33 from $30
* Avanos Medical Inc : Stephens raises target price to $38 from $30
* Axalta Coating Systems Ltd : Citigroup raises price target to $21 from $18
* Axalta Coating Systems Ltd : Credit Suisse cuts target price to $27 from $29
* Axalta Coating Systems Ltd : Jefferies raises target price to $18 from $15
* Axalta Coating Systems Ltd : Keybanc raises target price to $24 from $23
* Axcelis Technologies Inc : D.A. Davidson raises price target to $25 from $20
* Axcella Health Inc : BTIG raises target price to $12 from $10
* Axogen Inc : Canaccord Genuity cuts target price to $12 from $22
* Axogen Inc : Jefferies cuts target price to $21 from $30
* Bank of N.T. Butterfield & Son Ltd : Citigroup raises target to $21 from $15
* Barrett Business Services Inc : Barrington Research raises PT to $52 from $48
* Barrick Gold Corp : Deutsche Bank raises target price to $34 from $25
* Benefitfocus Inc : Piper Sandler cuts target price to $26 from $35
* Bio Rad Laboratories Inc : Citigroup raises price target to $525 from $480
* Bio Rad Laboratories Inc : Jefferies raises target price to $525 from $500
* Biocryst Pharmaceuticals Inc : Jefferies raises price target to $9 from $8
* Biocryst Pharmaceuticals Inc : Piper Sandler raises target price to $10 from $8
* Biotelemetry Inc : Benchmark cuts target price to $52 from $55
* Black Knight Inc : KBW raises target price to $70 from $68
* Black Knight Inc : Stephens raises target price to $88 from $84
* Black Knight Inc : Wedbush raises target price to $70 from $66
* Black Stone Minerals LP : Simmons Energy raises target price to $8 from $5
* Blackbaud Inc : Evercore ISI cuts target price to $48 from $55
* Blucora Inc : Benchmark cuts price target to $25 from $37
* BMC stock Holdings Inc : Stephens raises target price to $25 from $22
* BMC stock Holdings Inc : SunTrust Robinson raises price target to $26 from $22
* BorgWarner Inc : Jefferies raises target price to $33 from $30
* BorgWarner Inc : JP Morgan raises price target to $35 from $32
* BorgWarner Inc : Oppenheimer cuts target price to $44 from $45
* BorgWarner Inc : RBC raises target price to $31 from $29
* Boston Private Financial Holdings Inc : Piper Sandler raises PT to $7 from $6.
- 05/07/2020
|
The Chemours Company (NYSE: CC) Q1 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of The Chemours Co. - CC stock
- 05/07/2020
|
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
- Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIGHLIGHTS
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Lyft Inc : Piper Sandler cuts to neutral from overweight
* Natera Inc : JP Morgan raises to overweight from neutral
* Occidental Petroleum Corp : SunTrust Robinson raises to hold from sell
* Solaredge Technologies : Canaccord Genuity cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc : Citigroup cuts price target to $34 from $37
* Activision Blizzard Inc : Keybanc raises target price to $80 from $68
* Advanced Energy Industries Inc : Susquehanna cuts target price to $85 from $90
* Agco Corp : Stephens raises target price to $65 from $60
* Alexion Pharmaceuticals Inc : Credit Suisse cuts target price to $142 from $147
* Allegiant Travel Co : Cowen and Company cuts price target to $74 from $100
* Allstate Corp : Piper Sandler raises target price to $112 from $108
* Alnylam Pharmaceuticals Inc : JP Morgan cuts to neutral from overweight
* Alnylam Pharmaceuticals Inc : JP Morgan raises target price to $137 from $133
* Alnylam Pharmaceuticals Inc : Needham raises target price to $160 from $135
* Alnylam Pharmaceuticals Inc : Piper Sandler raises target price to $169 from $142
* Anaptysbio Inc : Credit Suisse raises target price to $16 from $14
* Arcus Biosciences Inc : Wedbush raises target price to $40 from $26
* Ares Management Corp : Credit Suisse raises target price to $40 from $38
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Ashland Global Holdings Inc. : JP Morgan cuts target price to $62 from $68
* Aspen Technology Inc : Keybanc raises target price to $120 from $110
* Astronics Corp : Canaccord Genuity cuts target price to $10 from $14
* Atkore International Group Inc : Citigroup raises price target to $26 from $24
* Atlas Corp (British Columbia) : Citigroup cuts price target to $7 from $12
* Axalta Coating Systems Ltd : Credit Suisse cuts target price to $27 from $29
* Axalta Coating Systems Ltd : Keybanc raises target price to $24 from $23
* Axogen Inc : Canaccord Genuity cuts target price to $12 from $22
* Bank of N.T. Butterfield & Son Ltd : Citigroup raises price target to $21 from $15
* Benefitfocus Inc : Piper Sandler cuts target price to $26 from $35
* Biocryst Pharmaceuticals Inc : Piper Sandler raises target price to $10 from $8
* Black Knight Inc : Stephens raises target price to $88 from $84
* Black Stone Minerals LP : Simmons Energy raises target price to $8 from $5
* Boston Private Financial Holdings Inc : Piper Sandler raises PT to $7 from $6.50
* Brookfield Business Partners LP : National Bank of Canada cuts PT to $38 from $42
* Brookfield Renewable Partners LP : CIBC raises target price to $49 from $48
* Catalent Inc : Stephens raises target price to $82 from $75
* Central Garden & Pet Co : Keybanc raises target price to $38 from $35
* Ceridian Hcm Holding Inc : Credit Suisse raises target price to $49 from $47
* Chefs' Warehouse Inc : Jefferies raises target price to $13 from $12
* Chemours Co : Jefferies raises target price to $13 from $11
* CNH Industrial : JP Morgan cuts target price to $6.50 from $8
* Consolidated Edison Inc : Credit Suisse cuts target price to $78 from $92
* Constellation Pharmaceuticals Inc : Jefferies raises target price to $63 from $53
* Lendingclub Corp : BTIG cuts target price to $11 from $23
* Cubic Corp : Canaccord Genuity cuts target price to $48 from $55
* Cytosorbents Corp : MKM Partners raises target price to $14 from $8
* Devon Energy Corp : Simmons Energy raises target price to $10 from $6
* Discovery Inc : MKM Partners cuts target price to $26 from $30
* Dupont : Citigroup raises price target to $52 from $47
* Dupont : Jefferies raises target price to $53 from $49
* Elevate Credit Inc : Credit Suisse cuts target price to $4 from $4.75
* Etsy Inc : Canaccord Genuity raises target price to $85 from $70
* Etsy Inc : Jefferies raises target price to $71 from $66
* Everbridge Inc : Stephens raises target price to $125 from $120
* Eversource Energy : Credit Suisse cuts target price to $81 from $92
* Evoqua Water Technologies Corp : Stifel raises target price to $22 from $21
* Exact Sciences Corp : Cowen and Company raises target price to $95 from $90
* Fastly Inc : Piper Sandler raises target price to $31 from $27
* First Western Financial Inc : Stephens cuts target price to $15 from $17
* Flir Systems Inc : Needham raises target price to $52 from $48
* FMC Corp : Citigroup raises price target to $114 from $107
* FMC Corp : Keybanc raises target price to $108 from $93
* Formfactor Inc : Cowen and Company raises target price to $24 from $22
* Formfactor Inc : D.A. Davidson raises target price to $25 from $20
* Fortinet Inc : Credit Suisse raises target price to $110 from $100
* Fortinet Inc : Piper Sandler raises target price to $125 from $110
* Fox Factory Holding Corp : Jefferies raises target price to $65 from $60
* Frontdoor Inc : Credit Suisse cuts target price to $44 from $50
* Gibraltar Industries Inc : Keybanc cuts target price to $55 from $60
* Global Payments Inc : Credit Suisse raises target price to $200 from $190
* Global Payments Inc : Jefferies raises target price to $195 from $175
* Global Payments Inc : Susquehanna raises target price to $205 from $200
* Graftech International Ltd : Credit Suisse cuts target price to $13 from $17
* Grubhub Inc : Jefferies raises target price to $50 from $48
* Heron Therapeutics Inc : Jefferies cuts target price to $31 from $33
* Hubspot Inc : Jefferies raises target price to $202 from $150
* Immunomedics Inc : Jefferies raises target price to $41 from $25
* Inmode Ltd : Canaccord Genuity cuts target price to $40 from $50
* Kennametal Inc : CFRA cuts target price to $25 from $32
* Kennametal Inc : JP Morgan cuts target price to $27 from $31
* Kforce Inc : Credit Suisse raises target price to $32 from $26
* KKR & Co Inc : Credit Suisse raises target price to $29 from $27
* Livongo Health Inc : Canaccord Genuity raises target price to $65 from $46
* Livongo Health Inc : Keybanc raises target price to $52 from $46
* Lyft Inc : D.A. Davidson raises target price to $35 from $27
* Lyft Inc : Jefferies cuts target price to $50 from $60
* Lyft Inc : Piper Sandler cuts price target to $31 from $63
* Lyft Inc : Piper Sandler cuts to neutral from overweight
* Magellan Midstream Partners LP : Credit Suisse raises target price to $48 from $42
* Martin Marietta Materials Inc : Citigroup raises price target to $230 from $228
* Natera Inc : Canaccord Genuity raises target price to $48 from $46
* Natera Inc : JP Morgan raises to overweight from neutral
* Natera Inc : JP Morgan raises target price to $45 from $32
* National Energy Services Reunited : National Bank of Canada cuts PT to $12 from
$13
* Neurocrine Biosciences Inc : Canaccord Genuity raises target to $123 from $122
* Neurocrine Biosciences Inc : Jefferies raises target price to $119 from $115
* Neurocrine Biosciences Inc : Mizuho raises target price to $105 from $103
* Neurocrine Biosciences Inc : Piper Sandler raises target price to $126 from $125
* Nlight Inc : Canaccord Genuity cuts target price to $22 from $25
* Now Inc : Stifel cuts target price to $6 from $7
* Nuvasive Inc : Canaccord Genuity cuts target price to $64 from $68
* Nuvasive Inc : Piper Sandler cuts target price to $75 from $90
* Occidental Petroleum Corp : SunTrust Robinson raises to hold from sell
* Occidental Petroleum Corp : SunTrust Robinson raises price target to $13 from $10
* Occidental Petroleum Corp : Susquehanna cuts target price to $12 from $13
* Palomar Holdings Inc : Piper Sandler raises target price to $64 from $54
* Papa John's International Inc : Credit Suisse raises target price to $84 from $71
* Papa John's International Inc : MKM Partners raises target price to $72 from $70
* Papa John's International Inc : Stifel raises target price to $95 from $80
* Parsley Energy Inc : Simmons Energy raises target price to $8 from $7.
- 05/07/2020
|
Edited Transcript of CC earnings conference call or presentation 6-May-20 12:30pm GMT
- Q1 2020 Chemours Co Earnings Call
- 05/06/2020
|
The Chemours Company (CC) Q1 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to the Chemours Company First quarter Earnings Call. Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operations and the other risks and uncertainties described in the documents Chemours has filed with the SEC.
- 05/06/2020
|
Why Chemours Stock Jumped 13% Today
- Shares of specialty chemical company Chemours (NYSE: CC) jumped nearly 14% as trading opened for the day. Although the company's titanium coatings business did well (sales were up 10% in the segment), its other two divisions (fluoroproducts and chemical solutions) saw year-over-year sales declines.
- 05/06/2020
|
Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1
- Decline volumes in the Fluoroproducts unit and lower global average prices across all segments hurt Chemours' (CC) Q1 sales.
- 05/06/2020
|
Chemours (CC) Tops Q1 Earnings Estimates
- Chemours (CC) delivered earnings and revenue surprises of 39.22% and -2.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/06/2020
|
Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1
- Stocks Analysis by Zacks Investment Research covering: S&P 500, SPDR S&P 500, Equinox Gold Corp, Chemours Co. Read Zacks Investment Research's latest article on Investing.com
- 05/06/2020
|
Teflon maker Chemours tops Q1 sales and profit views, withdraws guidance
- Shares of Chemours Co. gained more than 5% in the extended session Tuesday after the chemicals company reported first-quarter profit and sales above Wall Street expectations and said it planned to cut costs amid slower demand with the coronavirus pandemic. Chemours said it earned $100 million, or 61 cents a share, in the quarter, compared with $94 million, or 55 cents a share, in the year-ago period. Adjusted for one-time items, the company earned $118 million, or 71 cents a share, compared with 63 cents a share a year ago. Sales fell to $1.3 billion from $1.4 billion a year ago. Analysts polled by FactSet expected the company to report adjusted profit of 46 cents a share on sales of $1.3 billion. Chemours said all of its plants are operating "with minimal impact from COVID-19." To weather the slackened demand, however, the company said it aims to cut 2020 costs by $160 million and its capital expenditure plan by by $125 million to $275 million. Chemours said it had "ample" liquidity with no debt due in the near term. The company withdrew its 2020 guidance due to "current demand uncertainty, driven by COVID-19." Shares of Chemours had ended the regular trading day up nearly 12%.
- 05/05/2020
|
Why Shares of Chemours Are Soaring Today
- The company's former parent expects to settle a dispute over retained environmental liabilities.
- 05/05/2020
|
This Year's Tax-Loss-Selling Recovery Portfolio Is a Real Loser So Far
- This experiment in trying to identify stocks that could come back after dismal year-ago performance isn't going well five months since its inception.
- 05/01/2020
|
ARP Americas LP Takes $104,000 Position in Chemours Co (NYSE:CC)
- ARP Americas LP bought a new stake in shares of Chemours Co (NYSE:CC) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 11,729 shares of the specialty chemicals company’s stock, valued at approximately $104,000. Several other large investors also recently added to or reduced […]
- 05/01/2020
|
Chemours Announces Second Quarter Dividend
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the second quarter of 2020. The dividend will be paid on June 15, 2020 to stockholders of record as of the close of business on May 15, 2020.
- 04/28/2020
|
Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline
- Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
DuPont de Nemours, Inc. -- Moody's assigns Baa1 to DuPont's new notes; outlook stable
- Moody's Investors Service, ("Moody's") assigned Baa1 rating to DuPont de Nemours, Inc.'s (DuPont's) new senior unsecured notes maturing in 2023. "DuPont's new issuance will provide the financial flexibility to refinance their upcoming November maturity while maintaining a solid level of cash cushion during the coronavirus pandemic," said John Rogers, Senior Vice President at Moody's and lead analyst on DuPont.
- 04/28/2020
|
4THBIN Appoints Cynthia Salitsky as Chief Marketing Officer to Support Market Expansion and Drive Growth
- 4THBIN, a leading e-recycler, and data destruction company, announces today the appointment of Cynthia Salitsky as the company's Chief Marketing Officer (CMO). In this newly created role, Ms. Salitsky will join the senior leadership of the company and report to CEO Paul Kirsch. Ms. Salitsky will
- 04/28/2020
|
Investors In The Chemours Company (NYSE:CC) Should Consider This, First
- Dividend paying stocks like The Chemours Company (NYSE:CC) tend to be popular with investors, and for good reason...
- 04/28/2020
|
Chemours (CC) Set to Announce Earnings on Tuesday
- Chemours (NYSE:CC) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, May 5th. Analysts expect Chemours to post earnings of $0.55 per share for the quarter. Chemours has set its FY 2020 After-Hours guidance at 2.60-3.55 EPS and its FY20 guidance at $2.60-$3.55 EPS.Individual that are interested in registering […]
- 04/28/2020
|
Chemours Company, (The) -- Moody's downgrades Chemours to Ba3, Outlook negative
- Moody's Investors Service ("Moody's"), downgraded The Chemours Company's (Chemours) ratings, including the CFR to Ba3 from Ba2, the secured bank facilities to Ba1 from Baa3, and the senior unsecured rating to B1 from Ba3. The outlook on the ratings remains negative, reflecting the heightened and growing level of litigation risk stemming from actions filed by states, environmental regulators, water municipalities and private plaintiffs associated with perfluorochemicals (or PFAS), a family of chemicals used for decades to process a wide range of fluoropolymers. "The downgrade reflects the growing PFAS case load, its impact on the potential ultimate liability, and other adverse developments associated with PFAS litigation" according to Joseph Princiotta, Senior Vice President at Moody's. " The downgrade also reflects profit pressures in flouroproducts and TiO2 and the resulting stress to metrics and cash flow this year," Princiotta added.
- 04/27/2020
|
Contran Corp: Undervalued Assets Awaiting A Catalyst
- The late Harold Simmons left behind a manufacturing conglomerate of businesses, which trade at very attractive valuations. Due to Contran majority ownership, in
- 04/26/2020
|
Assenagon Asset Management S.A. Purchases Shares of 40,208 Chemours Co (NYSE:CC)
- Assenagon Asset Management S.A. bought a new position in shares of Chemours Co (NYSE:CC) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 40,208 shares of the specialty chemicals company’s stock, valued at approximately $357,000. A number of other hedge funds also recently added […]
- 04/26/2020
|
Macquarie Group Ltd. Boosts Position in Chemours Co (NYSE:CC)
- Macquarie Group Ltd. grew its holdings in shares of Chemours Co (NYSE:CC) by 150.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 690,450 shares of the specialty chemicals company’s stock after buying an additional 414,300 shares during the period. Macquarie Group Ltd.’s holdings in Chemours […]
- 04/25/2020
|
Chemours Co (NYSE:CC) Expected to Post Quarterly Sales of $1.34 Billion
- Analysts expect Chemours Co (NYSE:CC) to report $1.34 billion in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Chemours’ earnings. The lowest sales estimate is $1.34 billion and the highest is $1.35 billion. Chemours posted sales of $1.38 billion during the same quarter last year, which would suggest […]
- 04/21/2020
|
8 Basic Materials Stocks Moving In Monday's Pre-Market Session
- Losers
• China Natural Resources, Inc. (NASDAQ:CHNR) shares fell 25.74% to $0.75 during Monday's pre-market session.
• FutureFuel, Inc. (NYSE:FF) shares declined 20....
- 04/20/2020
|
Chemours (NYSE:CC) Shares Gap Down to $9.60
- Chemours Co (NYSE:CC) shares gapped down before the market opened on Thursday . The stock had previously closed at $9.19, but opened at $9.60. Chemours shares last traded at $8.90, with a volume of 89,908 shares. A number of research firms have recently commented on CC. Royal Bank of Canada cut their target price on […]
- 04/18/2020
|
Barclays Thinks Chemours Company's Stock is Going to Recover
- In a report released yesterday, Duffy Fischer from Barclays maintained a Buy rating on Chemours Company (CC), with a price target of $16.00. The company's
- 04/17/2020
|
Dow Futures, and Gilead Stock, Are Taking Off on Hopes for Virus Drug
- Stocks most affected by the viral outbreak are soaring, while those that have been havens for investors are down Friday morning. Trump’s plans for reopening the economy lifting the market, too.
- 04/17/2020
|
Easy Come, Easy Go: How Chemours (NYSE:CC) Shareholders Got Unlucky And Saw 76% Of Their Cash Evaporate
- The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
- 04/16/2020
|
Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The company will conduct its first quarter 2020 webcast conference call on Wednesday, May 6, 2020 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.
- 04/15/2020
|
Chemours (NYSE:CC) Price Target Cut to $17.00 by Analysts at Susquehanna Bancshares
- Chemours (NYSE:CC) had its price objective trimmed by Susquehanna Bancshares from $23.00 to $17.00 in a research note published on Tuesday, The Fly reports. CC has been the subject of a number of other reports. Royal Bank of Canada reduced their price target on shares of Chemours from $13.00 to $11.00 and set a sector […]
- 04/15/2020
|
Chemours Co (NYSE:CC) Shares Sold by Boenning & Scattergood Inc.
- Boenning & Scattergood Inc. trimmed its holdings in shares of Chemours Co (NYSE:CC) by 12.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,691 shares of the specialty chemicals company’s stock after selling 2,885 shares during the quarter. Boenning & Scattergood Inc.’s holdings […]
- 04/15/2020
|
Chemours (NYSE:CC) Given New $8.00 Price Target at Citigroup
- Chemours (NYSE:CC) had its target price trimmed by Citigroup from $10.00 to $8.00 in a research report sent to investors on Thursday, BenzingaRatingsTable reports. The brokerage currently has a neutral rating on the specialty chemicals company’s stock. Other equities research analysts have also issued reports about the stock. ValuEngine lowered shares of Chemours from a […]
- 04/13/2020
|
Ladenburg Thalmann Financial Services Inc. Decreases Position in Chemours Co (NYSE:CC)
- Ladenburg Thalmann Financial Services Inc. cut its stake in shares of Chemours Co (NYSE:CC) by 14.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,090 shares of the specialty chemicals company’s stock after selling 3,874 shares during the […]
- 04/13/2020
|
Geode Capital Management LLC Has $32.72 Million Position in Chemours Co (NYSE:CC)
- Geode Capital Management LLC lifted its holdings in shares of Chemours Co (NYSE:CC) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,808,996 shares of the specialty chemicals company’s stock after purchasing an additional 30,405 shares during […]
- 04/11/2020
|
Chemours Co (NYSE:CC) Shares Acquired by Bank of America Corp DE
- Bank of America Corp DE increased its stake in Chemours Co (NYSE:CC) by 23.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 333,474 shares of the specialty chemicals company’s stock after acquiring an additional 63,653 shares during the quarter. Bank of America Corp DE […]
- 04/11/2020
|
The Chemours Company Moves Annual Meeting of Shareholders to Virtual-Only Format
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced that the format of this year's Annual Meeting of Shareholders (the "Annual Meeting") has been changed from in-person to virtual-only.
- 04/10/2020
|
Here’s Why Chemours (NYSE:CC) Is Weighed Down By Its Debt Load
- Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
- 04/10/2020
|
The Global Titanium Dioxide Market is expected to grow from USD 19,896.13 Million in 2018 to USD 46,125.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.76%
- New York, April 08, 2020 -- Reportlinker.com announces the release of the report "Global Titanium Dioxide Market - Premium Insight, Competitive News Feed Analysis, Company.
- 04/09/2020
|
Is DuPont Stock a Buy?
- Unfortunate timing is taking its toll on DuPont.
- 04/08/2020
|
3,644,612 Shares in Chemours Co (NYSE:CC) Bought by Norges Bank
- Norges Bank bought a new position in Chemours Co (NYSE:CC) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 3,644,612 shares of the specialty chemicals company’s stock, valued at approximately $65,931,000. Norges Bank owned 2.22% of Chemours as of its most recent SEC filing. A […]
- 04/08/2020
|
Cramer Advises His Viewers On New Residental, Prudential Financial And More
- On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't even need to tinker with a company that cut its dividend. He is not a buyer of New Residential...
- 04/07/2020
|
Chemours (NYSE:CC) PT Lowered to $11.00 at Cfra
- Chemours (NYSE:CC) had its price objective cut by Cfra from $21.00 to $11.00 in a report issued on Friday morning, BenzingaRatingsTable reports. They currently have a hold rating on the specialty chemicals company’s stock. A number of other brokerages have also issued reports on CC. Zacks Investment Research lowered shares of Chemours from a hold […]
- 04/07/2020
|
Chemours (CC) - Investment Analysts' Recent Ratings Updates
- Several brokerages have updated their recommendations and price targets on shares of Chemours (NYSE: CC) in the last few weeks: 4/3/2020 – Chemours had its price target lowered by analysts at Cfra from $21.00 to $11.00. They now have a “hold” rating on the stock. 4/2/2020 – Chemours was downgraded by analysts at ValuEngine from […]
- 04/07/2020
|
Chemours to borrow from its revolving credit facility
- Chemours (CC +12.0%) says that out of caution, it will borrow $300M from its $800M revolving credit facility.CC states that there were no borrowings outstanding on the revolving credit facility at the
- 04/06/2020
|
Chemours Provides Update in Response to Coronavirus Outbreak
- Chemours (CC) is likely to use the $300-million proceeds from borrowings in the future for working capital needs or other general corporate purposes.
- 04/06/2020
|
Chemours Provides Update in Response to Coronavirus Outbreak
- Chemours (CC) is likely to use the $300-million proceeds from borrowings in the future for working capital needs or other general corporate purposes.
- 04/06/2020
|
Macquarie Group Ltd. Grows Position in Chemours Co (NYSE:CC)
- Macquarie Group Ltd. raised its holdings in Chemours Co (NYSE:CC) by 150.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 690,450 shares of the specialty chemicals company’s stock after acquiring an additional 414,300 shares during the quarter. Macquarie Group Ltd.’s holdings in Chemours were worth $12,490,000 at the end of the most recent reporting […]
- 04/06/2020
|
Inorganic Pigment Market 2025 – Global Insights on Competitive Landscape, Leading Players Overview, Demand Forecast, Key Growth Drivers, Value Chain Analysis and Future Prospect: Adroit Market Research
- Dallas, Texas, April 06, 2020 -- The “Inorganic Pigment Market by Derivative (Titanium Dioxide, Iron Oxide, Carbon Black, Others), Application (Textiles, Printing Inks,.
- 04/06/2020
|
Chemours Co to Post Q3 2020 Earnings of $0.61 Per Share, SunTrust Banks Forecasts (NYSE:CC)
- Chemours Co (NYSE:CC) – Analysts at SunTrust Banks reduced their Q3 2020 earnings per share (EPS) estimates for Chemours in a report released on Thursday, April 2nd. SunTrust Banks analyst J. Sheehan now forecasts that the specialty chemicals company will earn $0.61 per share for the quarter, down from their prior forecast of $0.80. SunTrust […]
- 04/06/2020
|
SunTrust Banks Equities Analysts Reduce Earnings Estimates for Chemours Co (NYSE:CC)
- Chemours Co (NYSE:CC) – Research analysts at SunTrust Banks decreased their Q1 2020 earnings per share (EPS) estimates for Chemours in a report issued on Thursday, April 2nd. SunTrust Banks analyst J. Sheehan now forecasts that the specialty chemicals company will post earnings of $0.52 per share for the quarter, down from their prior estimate […]
- 04/05/2020
|
Chemours to tap $300 million from loan facility
- The Chemours Co. said late Friday that it was drawing $300 million from its $800 million revolving credit facility "out of an abundance of caution" amid the economic destruction wreaked by the novel coronavirus pandemic. "This action helps to balance our access to domestic and non-domestic cash, and increase our near-term financial flexibility," Chief Executive Mark Vergnano said in a statement. Repaying the $300 million will happen "when the uncertainty in the global markets subsides," the chemicals company said. Chemours confirmed it had cash and cash equivalents plus borrowing capacity around $1.6 billion as of Dec. 31. It said it had no upcoming maturities of senior debt until 2023. "While the current environment remains uncertain, we remain confident in our financial position, the strength of our businesses, and the long-term prospects for Chemours," Vergnano said. Shares of Chemours fell 1.5% in the extended session after ending the regular trading day down 3.3%.
- 04/03/2020
|
The Chemours Company Provides COVID-19 Update
- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced action it is taking to address macroeconomic uncertainty driven by the coronavirus (COVID-19).
- 04/03/2020
|
DuPont: New Management Reaffirms 2020 EPS, Trims Sales Guidance, Attractive 8% Options Yields
- DuPont recently replaced its CEO and CFO. It received a favorable judgment in the Chemours lawsuit. Management reaffirmed 2020 guidance that reaffirmed Adjusted
- 04/03/2020
|
BI Asset Management Fondsmaeglerselskab A S Acquires 42,525 Shares of Chemours Co (NYSE:CC)
- BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of Chemours Co (NYSE:CC) by 56.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 117,538 shares of the specialty chemicals company’s stock after acquiring an additional 42,525 shares […]
- 04/02/2020
|
Chemours (NYSE:CC) Reaches New 52-Week Low Following Analyst Downgrade
- Chemours Co (NYSE:CC) shares hit a new 52-week low during trading on Wednesday after Royal Bank of Canada lowered their price target on the stock from $13.00 to $11.00. Royal Bank of Canada currently has a sector perform rating on the stock. Chemours traded as low as $8.01 and last traded at $8.02, with a […]
- 04/02/2020
|
Exclusive: Insiders at these Philadelphia-area companies are buying up the most stock amid coronavirus downturn
- Insiders at Philadelphia area companies bought up a total of more than $12 million in their own firms' stock in the past 30 days. Above, the bull near Wall Street in New York.
- 04/01/2020
|
Analysts Offer Insights on Consumer Goods Companies: Palo Alto Networks (PANW), NCR (NCR) and Chemours Company (CC)
- Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Palo Alto Networks (PANW), NCR (NCR) and Chemours
- 04/01/2020
|
Are Options Traders Betting on a Big Move in Chemours (CC) Stock?
- Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
- 04/01/2020
|
Are Options Traders Betting on a Big Move in Chemours (CC) Stock?
- Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
- 04/01/2020
|
Short Interest in Chemours Co (NYSE:CC) Increases By 10.5%
- Chemours Co (NYSE:CC) was the recipient of a large growth in short interest in the month of March. As of March 13th, there was short interest totalling 16,479,800 shares, a growth of 10.5% from the February 27th total of 14,910,000 shares. Based on an average daily volume of 3,190,000 shares, the short-interest ratio is currently […]
- 04/01/2020
|
Chemours' enviro liability complaint v. DuPont must go to arbitration - Dela. court
- A Delaware state court has tossed a lawsuit by the Chemours Company, an E.I. du Pont de Nemours and Company spinoff, that alleged its former parent had unlawfully "spectacularly underestimated" Chemours' exposure to environmental liabilities when creating the company in 2015.
- 03/31/2020
|
Why Shares of Chemours Were Down Today
- The company was dealt a blow in a legal battle against its former parent.
- 03/31/2020
|
Chemours lawsuit against DuPont dismissed
- A Delaware judge has granted DuPont's (DD +3.4%) request to dismiss a lawsuit alleging that it downplayed the cost of environmental liabilities imposed on spinoff company Chemours (CC -7%).The judge r
- 03/31/2020
|
Connor Clark & Lunn Investment Management Ltd. Sells 384,979 Shares of Chemours Co (NYSE:CC)
- Connor Clark & Lunn Investment Management Ltd. lessened its holdings in Chemours Co (NYSE:CC) by 28.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 978,564 shares of the specialty chemicals company’s stock after selling 384,979 shares during the period. […]
- 03/31/2020
|
Chemours (NYSE:CC) Shares Gap Down After Analyst Downgrade
- Chemours Co (NYSE:CC) shares gapped down before the market opened on Monday after Morgan Stanley lowered their price target on the stock from $15.00 to $12.00. The stock had previously closed at $8.64, but opened at $9.51. Morgan Stanley currently has an equal weight rating on the stock. Chemours shares last traded at $9.69, with […]
- 03/31/2020
|
Judge dismisses Chemours lawsuit against DuPont
- DOVER, Del. (AP) — A Delaware judge has granted the DuPont Co.'s request to dismiss a lawsuit alleging that it massively downplayed the cost of environmental liabilities imposed on spinoff company Chemours. Vice Chancellor Sam Glasscock III ruled Monday that he has no jurisdiction to hear the case because the separation agreement between the companies clearly states that all disputes arising from the spinoff are subject to binding arbitration. DuPont issued a statement saying it was pleased with the ruling and would take steps to enforce its rights under the separation agreement. A Chemours spokesman said the company will appeal the ruling to the Delaware Supreme Court. Chemours sued DuPont last year, alleging DuPont deliberately lowballed the cost of environmental liabilities Chemours would face in reimbursing DuPont for pollution related to man-made chemicals known as per- and polyfluoroalkyl substances, or PFAS. The chemicals have been used in firefighting foam, nonstick cookware, water-repellent clothing and many other household and personal items. They sometimes are referred to as "forever chemicals" because of their longevity in the environment. The PFAS family of chemicals, which have been associated with increased risk of cancer and other health problems, includes perfluorooctanoic acid, or PFOA, which was used in the production of Teflon. When it spun off its former performance chemicals unit in 2015, DuPont was facing multidistrict litigation involving 3,500 personal injury claims related to PFOA. DuPont pegged the maximum liability for those cases at $128 million. Dupont settled 19 months later for $671 million, agreeing to pay half the settlement amount, and up to $125 million more toward costs of other PFOA-related litigation. Chemours paid the other...
- 03/30/2020
|
Judge dismisses Chemours lawsuit against DuPont
- A Delaware judge has granted the DuPont Co.'s request to dismiss a lawsuit alleging that it massively downplayed the cost of environmental liabilities imposed on spinoff company Chemours. Vice Chancellor Sam Glasscock III ruled Monday that he has no jurisdiction to hear the case because the separation
- 03/30/2020
|
Morgan Stanley Keeps a Hold Rating on Chemours Company (CC)
- Morgan Stanley analyst Vincent Andrews maintained a Hold rating on Chemours Company (CC) today and set a price target of $12.00. The company's shares
- 03/30/2020
|
Chemours Lawsuit Over Liability From DuPont Spinoff Tossed
- Chemours Co. must use arbitration to resolve a dispute with former parent DuPont de Nemours Inc. over environmental liabilities shifted to the spin-off when the chemical makers were separated in 2015, a judge ruled.Delaware Chancery Court Judge Sam Glasscock III concluded a valid arbitration clause in the separation agreement mandated that all disputes were to be heard outside the regular courts. Chemours argued the arbitration provisions were so onerous they shouldn’t be enforced and DuPont’s e
- 03/30/2020
|
Alberta Investment Management Corp Sells 454,100 Shares of Chemours Co (NYSE:CC)
- Alberta Investment Management Corp cut its holdings in shares of Chemours Co (NYSE:CC) by 93.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,000 shares of the specialty chemicals company’s stock after selling 454,100 shares during the period. Alberta Investment […]
- 03/30/2020
|
Chemours Co Expected to Earn Q1 2020 Earnings of $0.53 Per Share (NYSE:CC)
- Chemours Co (NYSE:CC) – Stock analysts at SunTrust Banks lowered their Q1 2020 earnings estimates for shares of Chemours in a report issued on Wednesday, March 25th. SunTrust Banks analyst J. Sheehan now anticipates that the specialty chemicals company will post earnings per share of $0.53 for the quarter, down from their prior forecast of […]
- 03/30/2020
|
Do Hedge Funds Love Ameris Bancorp (ABCB)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/29/2020
|
Is Penn National Gaming, Inc (PENN) A Good Stock To Buy?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/29/2020
|
Do Hedge Funds Love PTC Therapeutics, Inc. (PTCT)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/29/2020
|
Chemours Co (NYSE:CC) Shares Purchased by Bank of New York Mellon Corp
- Bank of New York Mellon Corp raised its stake in shares of Chemours Co (NYSE:CC) by 18.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,194,798 shares of the specialty chemicals company’s stock after purchasing an additional 500,177 shares during the period. Bank of New […]
- 03/29/2020
|
$1.39 Billion in Sales Expected for Chemours Co (NYSE:CC) This Quarter
- Equities research analysts expect Chemours Co (NYSE:CC) to post $1.39 billion in sales for the current quarter, according to Zacks. Two analysts have made estimates for Chemours’ earnings. The highest sales estimate is $1.44 billion and the lowest is $1.34 billion. Chemours reported sales of $1.38 billion in the same quarter last year, which indicates […]
- 03/29/2020
|
ValuEngine Downgrades Chemours (NYSE:CC) to Sell
- Chemours (NYSE:CC) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, ValuEngine reports. CC has been the subject of several other research reports. Jefferies Financial Group cut shares of Chemours from a “buy” rating to a “hold” rating in a research report on […]
- 03/29/2020
|
Hedge Funds Have Never Been More Bullish On Cohen & Steers, Inc. (CNS)
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/29/2020
|
Hedge Funds Were Getting Burned By The Chemours Company (CC) Before The Coronavirus
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/29/2020
|
13,756 Shares in Chemours Co (NYSE:CC) Bought by Blueshift Asset Management LLC
- Blueshift Asset Management LLC purchased a new position in shares of Chemours Co (NYSE:CC) during the 4th quarter, Holdings Channel.com reports. The fund purchased 13,756 shares of the specialty chemicals company’s stock, valued at approximately $249,000. A number of other institutional investors have also recently added to or reduced their stakes in CC. Chevy Chase […]
- 03/28/2020
|
Chemours (NYSE:CC) Shares Down 12.1% After Analyst Downgrade
- Chemours Co (NYSE:CC) dropped 12.1% on Friday after ValuEngine downgraded the stock from a hold rating to a sell rating. The stock traded as low as $9.19 and last traded at $9.51, approximately 4,277,330 shares traded hands during trading. An increase of 18% from the average daily volume of 3,615,161 shares. The stock had previously […]
- 03/28/2020
|
Water & Wastewater Treatment Chemicals Industry, Forecast to 2029 - Featuring AkzoNobel, Albemarle, Chembond Chemicals, Ecolab, K+ S AG Water Industries, Kemira OYJ, and More
- The "Global Water and Wastewater Treatment Chemicals Market: Focus on Type and End Users (Municipal, Power Generation, Oil & Gas, Paper & Pulp, Mining, Food & Beverage, Chemicals, and Others) - Analysis and Forecast, 2019-2029" report has been added to ResearchAndMarkets.com's offering.
- 03/27/2020
|
Brokerages Expect Chemours Co (NYSE:CC) to Post $0.58 Earnings Per Share
- Equities research analysts expect Chemours Co (NYSE:CC) to post earnings per share of $0.58 for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Chemours’ earnings. The lowest EPS estimate is $0.49 and the highest is $0.66. Chemours posted earnings per share of $0.63 in the same quarter last year, which […]
- 03/27/2020
|
Advisor Group Inc. Trims Stock Holdings in Chemours Co (NYSE:CC)
- Advisor Group Inc. trimmed its holdings in Chemours Co (NYSE:CC) by 25.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,090 shares of the specialty chemicals company’s stock after selling 6,069 shares during the period. Advisor Group Inc.’s holdings in Chemours were […]
- 03/27/2020
|
Chemours Company (CC) Gets a Hold Rating from RBC Capital
- RBC Capital analyst Arun Viswanathan maintained a Hold rating on Chemours Company (CC) today and set a price target of $13.00. The company's shares closed
- 03/26/2020
|
Analysts Are Bullish on These Consumer Goods Stocks: Chemours Company (CC), Ferrari (RACE)
- There's a lot to be optimistic about in the Consumer Goods sector as 3 analysts just weighed in on Chemours Company (CC), Ferrari (RACE) and Nike (NKE)
- 03/26/2020
|
Global Water & Wastewater Treatment Chemicals Market 2019-2029: Focus on Type and End-users (Municipal, Power Generation, Oil & Gas, Paper & Pulp, Mining, Food & Beverage, Chemicals & Others)
- Dublin, March 26, 2020 -- The "Global Water and Wastewater Treatment Chemicals Market: Focus on Type and End Users (Municipal, Power Generation, Oil & Gas, Paper &.
- 03/26/2020
|
Advisors Asset Management Inc. Buys 165,775 Shares of Chemours Co (NYSE:CC)
- Advisors Asset Management Inc. grew its stake in Chemours Co (NYSE:CC) by 120.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 303,272 shares of the specialty chemicals company’s stock after purchasing an additional 165,775 shares during the quarter. Advisors Asset Management Inc.’s holdings in Chemours were worth $5,486,000 at the end of the […]
- 03/26/2020
|
Here's Why You Should Hold Onto Chemours (CC) Stock Now
- Chemours (CC) should gain from its actions to drive Opteon adoption and boost productivity across its business segments in 2020.
- 03/25/2020
|
Here's Why You Should Hold Onto Chemours (CC) Stock Now
- Chemours (CC) should gain from its actions to drive Opteon adoption and boost productivity across its business segments in 2020.
- 03/25/2020
|
Is The Chemours Company (NYSE:CC) Trading At A 48% Discount?
- In this article we are going to estimate the intrinsic value of The Chemours Company (NYSE:CC) by taking the expected...
- 03/25/2020
|
Envestnet Asset Management Inc. Sells 112,594 Shares of Chemours Co (NYSE:CC)
- Envestnet Asset Management Inc. lowered its stake in Chemours Co (NYSE:CC) by 70.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 47,894 shares of the specialty chemicals company’s stock after selling 112,594 shares during the quarter. Envestnet Asset Management Inc.’s holdings […]
- 03/25/2020
|
Chemours (NYSE:CC) Trading 16.4% Higher
- Chemours Co (NYSE:CC) shares traded up 16.4% on Tuesday . The stock traded as high as $9.77 and last traded at $9.56, 4,087,070 shares changed hands during trading. An increase of 16% from the average session volume of 3,527,027 shares. The stock had previously closed at $8.21. Several equities research analysts recently weighed in on […]
- 03/25/2020
|
BRIEF-John Petry Reports 5.5% Passive Stake In Chemours Co As Of March 12, 2020 - SEC Filing
|
Global Water and Wastewater Treatment Chemicals Market: Focus on Type and End Users - Analysis and Forecast, 2019-2029
- The Global Water and Wastewater Treatment Chemicals Market Anticipated to Reach to $37.20 Billion by 2029
- 03/23/2020
|
Things May Get Bad, but RCL Stock Still Has a Way Forward
- The Diamond Princess -- the cruise ship that became the epicenter for the coronavirus outbreak outside of China -- was not owned by Royal Caribbean Cruises (NYSE:RCL). However, the entire cruise industry quickly felt the effects of the crisis. Cruises are on hold globally, and cruise lines are lobbying for a bailout. At this point, RCL stock is down 82% in 2020.Source: Laszlo Halasi / Shutterstock.com With taxpayers up in arms about the prospect of an industry bailout, multiple cruise ships still unable to find a port willing to let them dock, and the global coronavirus pandemic worsening, is it game over for Royal Caribbean? Or is this the opportunity of a lifetime to snap up RCL before the stock recovers?Few sectors have been hammered as badly over the past month as the cruise industry. Since the Diamond Princess was quarantined in Japan over confirmed coronavirus cases on February 4, cruise lines have seen their stocks sink in value.InvestorPlace - Stock Market News, Stock Advice & Trading TipsRCL is down 82% so far this year. Carnival (NYSE:CCL) -- the parent company of Princess Cruises (operator of the ill-fated Diamond Princess) -- has slumped 80%. Norwegian Cruise Line (NYSE:NCLH) is down by 84% so far this year. * 10 of the Best Long-Term Stocks to Buy in a Bear Market At this point, 21 cruise ships are known to have been affected by the coronavirus pandemic. Passengers are ill with the virus, there have been passenger deaths, or the ships are sailing the oceans in a futile attempt to find a port willing to let them dock. A Global Perspective on RCL StockMost global cruise lines have announced they are suspending operations for at least the next month. Headlines are beginning to speculate the coronavirus may well spell the end of the $45 billion U.S. cruise industry.Speaking to The Guardian, Boston University school of hospitality administration professor Dr. Christopher Muller explains why this is a disastrous time for the cruise industry. He says cruise lines will feel the impact even worse than airlines:"When you have 3,500 people booked on one of these mega cruises and the boat doesn't go, it's an enormous expense. Someone's paying for that boat that's sitting idle in the harbor and it's very hard to recapture those ongoing fixed-cost losses. Airlines have much smaller capacity vehicles, so while grounding a 150- or even 400-seat airplane is expensive, they can react much quicker."What about talk of bailouts? While the President favors financial assistance for the struggling cruise industry, Democrats are pushing back. A big problem is the way cruise lines have operated. American cruise lines have employed various strategies including flying their ships under foreign flags specifically to avoid paying U.S. taxes and to pay workers lower wages.That hasn't endeared companies like Royal Caribbean to the public, especially when they turn around and ask for government assistance using taxpayer dollars. Bottom Line on RCL StockThe knee-jerk reaction is to write off cruise lines as toast in the aftermath of the coronavirus pandemic. Massive cruise ships were front and center during the early stages of the coronavirus crisis, with images of quarantined passengers on the front page. Cruises are on halt for at least a month. Ships full of anxious passengers are still in the headlines as they sail from port to port, looking for a country willing to let them disembark.It definitely looks bad for the industry.But there is still room for hope for Royal Caribbean. There's the possibility of financial assistance from the U.S. government. Even without that, cruise patrons have an infamously short memory.Do you even remember the 700 passengers sickened by a norovirus outbreak on Royal Caribbean's Explorer of the Seas in 2014? If history repeats, the image of passengers trapped on the balconies of the Diamond Princess as it was docked in Japan -- while harboring hundreds of coronavirus infections -- will likely fade.That's why investment analysts have an average 12-month price target of over $100 for Royal Caribbean. They don't necessarily see RCL stock recovering fully to its record highs any time soon, but they don't see this cruise line going under, either. InvestorPlace's Will Ashworth has Royal Caribbean featured as one of his seven service stocks to buy on coronavirus weakness. He notes that "RCL stock is cheaper than it has been on a valuation basis since 9/11," and points out that the company remains under the direction of a capable CEO who's been tested by crisis before.In short, RCL stock is bound to continue feeling the impact of the coronavirus for some time to come. It may not have hit bottom yet. However, this cruise line is well-positioned to set sail again -- as is RCL stock.As of this writing, Brad Moon did not hold a position in any of the aforementioned securities. More From InvestorPlace * America's Richest ZIP Code Holds Wealth Gap Secret * 10 of the Best Long-Term Stocks to Buy in a Bear Market * 7 "Perfect 10" Healthcare Stocks to Buy Now * Where the FANG Stocks Sit in This Wild Market The post Things May Get Bad, but RCL Stock Still Has a Way Forward appeared first on InvestorPlace.
- 03/20/2020
|
Jefferies Financial Group Comments on Chemours Co's FY2020 Earnings (NYSE:CC)
- Chemours Co (NYSE:CC) – Investment analysts at Jefferies Financial Group reduced their FY2020 EPS estimates for Chemours in a research report issued to clients and investors on Sunday, March 15th. Jefferies Financial Group analyst L. Alexander now anticipates that the specialty chemicals company will earn $2.60 per share for the year, down from their previous […]
- 03/19/2020
|
Chevy Chase Trust Holdings Inc. Invests $28,000 in Chemours Co (NYSE:CC)
- Chevy Chase Trust Holdings Inc. purchased a new position in shares of Chemours Co (NYSE:CC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,596 shares of the specialty chemicals company’s stock, valued at approximately $28,000. Other hedge funds and other institutional […]
- 03/18/2020
|
Chemours Co (NYSE:CC) Insider E Bryan Snell Acquires 11,000 Shares of Stock
- Chemours Co (NYSE:CC) insider E Bryan Snell acquired 11,000 shares of the business’s stock in a transaction on Friday, March 13th. The stock was purchased at an average price of $10.15 per share, for a total transaction of $111,650.00. Following the acquisition, the insider now directly owns 141,891 shares in the company, valued at $1,440,193.65. […]
- 03/17/2020
|
The President of Chemours Company (CC) is Buying Shares
- Today, the President of Chemours Company (CC), Snell E Bryan, bought shares of CC for $111.7K. Following this transaction Snell E Bryan's holding in the
- 03/16/2020
|
Chemours Co (NYSE:CC) Sees Large Decrease in Short Interest
- Chemours Co (NYSE:CC) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 14,910,000 shares, a decrease of 5.0% from the February 13th total of 15,700,000 shares. Approximately 9.2% of the company’s stock are short sold. Based on an average trading volume of 3,190,000 […]
- 03/16/2020
|
Atria Investments LLC Decreases Stock Holdings in Chemours Co (NYSE:CC)
- Atria Investments LLC trimmed its holdings in shares of Chemours Co (NYSE:CC) by 76.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,939 shares of the specialty chemicals company’s stock after selling 51,100 shares during the quarter. Atria Investments LLC’s holdings in Chemours were […]
- 03/15/2020
|
Chemours (CC) Down 34.3% Since Last Earnings Report: Can It Rebound?
- Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 03/14/2020
|
